•CoverFINAL
4/4/08
3:54 PM
Page 4
R E S E A R C H + R E S U LT S
Albany College of Pharmacy P R E S I D E N T ’ S R E P O R T 2007
•CoverFINAL
4/4/08
3:54 PM
Page 1
M A N A G I N G E D I TO R Christine Shields E D I TO R Gil Chorbajian CO N T R I B U T I N G W R I T E R S Shannon Ballard Gil Chorbajian James J. Gozzo, Ph.D. Patrick Rathbun Christine Shields CO N T R I B U T I N G P H OTO G R A P H E R S Gil Chorbajian Mark McCarty Kris Qua Patrick Rathbun Christine Shields DESIGN Coppola Design www.coppoladesign.com
ACPPresRepFINAL
4/4/08
3:57 PM
Page 1
P1
Albany College of Pharmacy PRESIDENT’S REPORT 2007
>
Contents PRESIDENT’S MESSAGE
2
N E W FA C U LT Y A D D N E W D I M E N S I O N S
4
CO L L A B O R AT I O N P R O PA G AT I O N
6
N AT U R E - C E U T I C A L S : B R I D G I N G S C I E N C E A N D P R A C T I C E
8
WH EN GOOD CELLS GO BAD
10
WAT E R , WAT E R E V E RY W H E R E
19
D I V I N G I N TO WAT E R Q UA L I T Y
24
AN ELECTRIFYING EXPERIENCE
25
S U M M E R R E S E A R C H TA K E S N O B R E A K
26
L E G I S L AT I V E S E S S I O N
28
S C H O L A R LY A C T I V I T Y
29
FI NANCIALS
42
R E P O RT O F G I F T S
44
ACPPresRepFINAL
4/4/08
3:57 PM
Page 2
President’s Message
At Albany College of Pharmacy, we enjoy a strong reputation as a pharmacy college, but we aspire to something even greater — > In order to realize this objective, we
under the direction of Dr. Shaker
are expanding our course offerings,
Mousa to broaden the College’s research
strengthening the college’s research
capabilities, and it remains a facility
capabilities and planning the addition
unrivaled by our peers in terms of its
of a new campus.
talent, resources and accomplishments.
While
the
Pharm.D.
program
The Pharmaceutical Research Institute
remains central to our mission, we
and ACP faculty secured a total of 29
recently announced the addition of a
grants for external funding in 2007,
B.S. degree in health and human sci-
totaling nearly two million dollars.
ences, complementing our existing
While we have made significant
B.S. programs in biomedical technolo-
progress in recent years in enhancing
gy and pharmaceutical sciences. We
our educational programs, we antici-
also received approval from the New
pate even more opportunities to build
York State Education Department this
on these successes in the years ahead.
past year for our first two master’s
One of those opportunities will be
degree programs — in health out-
the opening of our new campus in
comes and pharmacy administration.
Colchester, Vermont, located just out-
In addition, we continue to offer
side of Burlington. Bob Hamilton,
joint degree options with Albany
Pharm.D., a 1977 graduate of ACP who
Medical Center, Albany Law School
has been a faculty member and
and Union Graduate College.
administrator at the College for 25
The Pharmaceutical Research Institute
years, will head the campus. The deci-
(PRI),now located at UAlbany’s Gen*NY*Sis
sion to open a satellite campus pro-
Center for Excellence in Cancer Genomics
vides us with an excellent opportunity
in Rensselaer, was formed in 2004
to help Vermont address its pharma-
ACPPresRepFINAL
4/4/08
3:57 PM
Page 3
P3
Albany College of Pharmacy PRESIDENT’S REPORT 2007
to be viewed as a truly extraordinary institute of higher learning.
cist shortage, a situation that is
Of course, none of these achieve-
impacted by the fact that Vermont is
ments would be possible without the
just one of three states in the country
unwavering
without a pharmacy program. The
College’s Board of Trustees, faculty,
state’s progressive health care system
staff, administration, students, alumni
will also afford students completing
and friends. Their dedication to sup-
their experiential education opportu-
porting the overall mission of the
nities to put their knowledge into
College is both recognized and essen-
practice in areas such as immuniza-
tial as we pursue excellence in all that
tion and medication therapy man-
we do.
agement (MTM).
commitment
of
the
Without question, we are in a period
As we look to the future, we are
of significant growth and development
also thinking of the next generation.
which will continue. We welcome you
In 2007,we launched the “ACP Academy,”
to join us in this effort.
an after-school program which reaches out to disadvantaged youths in the community (beginning in 3rd grade) and, through the use of ACP students as mentors, provides a gradually intensive science and math curriculum through their senior years of high school. We will welcome a new group of students into the program in fall 2008 and plan to add a new class each successive year.
JA M E S J . G OZ Z O, P H . D.
ACPPresRepFINAL
4/4/08
3:57 PM
Page 4
TA L E N T P O O L
New Faculty Add New Dimensions to ACP As the College expands into new areas of instruction and research, there is a corresponding need for specialized faculty who can help foster this growth. It is not enough, however, for prospective hires to simply possess the required academic credentials; faculty members must also be able to inspire students and contribute new knowledge. Below is a summary of six people who meet these criteria and who joined the ACP faculty in the 2006–2007 academic year.
Kim Bachta, M.S., RPA-C Department of Health Sciences Director of Pre-Physician Assistant Studies program One of the newest programs at ACP is a joint physician assistant’s degree through ACP and Albany Medical College (AMC). The program entails 3V years at ACP followed by 2V years at the Medical College. Kim Bachta, a faculty member at both institutions and a clinically practicing physician assistant (PA), is the director of the program. Bachta is a member of ACP’s department of Health Sciences, focusing her time on assisting with curriculum development and interviewing students applying to the program. Her role with admissions is especially important given one of the most appealing aspects of the program — automatic admission into AMC’s competitive master’s program in physician assistant studies. Bachta estimates that there will be 300-400 applicants for 30 spots in the AMC program next year, making ACP an attractive option for students who want to lock in a coveted spot at AMC. In addition to her many responsibilities, Bachta recently found time to travel on a medical mission to Nicaragua, and she hopes to soon do a similar mission to Africa to work with AIDS patients. “You have to be able to go home every day and say you love your job, and I do.”
Patricia L. Baia, M.S, A.B.D Department of Arts and Sciences Instructor, Instructional Technologist The availability of new technologies for discovering and delivering information has made a profound impact on how we live and work.Through the assistance of Patricia L. Baia, M.S., A.B.D., ACP faculty are exploring how new and current technologies such as distance learning, audio and video, blogs, podcasts and wikis can be more widely deployed in the classroom and beyond.
Baia is an instructional technologist, who serves a dual role teaching first year courses in communications and writing and helping faculty evaluate the use of technology in their curriculums. She also joins the College’s Teaching and Learning Commons, a network of advising, learning and teaching resources for students and faculty that debuted last spring. Despite joining ACP just over a year ago, her presence is already making an impact. Before Baia’s arrival, ACP did not offer any distance learning classes; by next fall, the College expects to have 7-10 such courses available. Patty is also the founder of the Capital District Educational Technology Group (www.cdetg.org), an Albany-based organization comprised of local colleges and universities that shares best practices for using technology inside and outside the classroom. “The fact that ACP requires every student and faculty member to own a laptop sets the College apart from most other institutions of higher learning and opens up the possibilities for many dynamic approaches to teaching.”
Alexandre Bridoux, Ph.D. Pharmaceutical Research Institute Postdoctoral fellow Alexandre Bridoux joined PRI after receiving his Ph.D. in chemistry from the University of Lille in his native France. The focus of his post-doctoral work at PRI is on angiogenesis — the growth of new blood vessels from pre-existing vessels. Angiogenesis occurs when thyroxine is secreted in large quantities by the thyroid gland or when a synthetic equivalent of the hormone is injected into the body. By creating new blood vessels, angiogenesis has the ability to make cells ’sprout’ from existing vessels and may help repair the impact of a stroke. However, if an excess of thyroxine passes through a cell’s surface and enters the nucleus, the result can affect the body’s rate of blood flow, which can have dangerous consequences. Bridoux is working with the NanoPharmaceuticals group at PRI to avoid this phenomenon by attaching a nanoparticle to a synthetic thyroxine hormone, which will allow the beneficial effects of angiogenesis without interfering with the natural rate of blood flow. He uses the metaphor of attaching a basketball to a marble, allowing the marble to fit through a small opening but not penetrate any deeper. One compound has already been developed from the research and sent to an animal lab for further study. “The work we are doing here has a real future as a drug.”
ACPPresRepFINAL
4/4/08
3:57 PM
Page 5
P5
Baia
Bridoux
Arnold Johnson, Ph.D. Department of Pharmaceutical Sciences Professor of Pharmaceutical Sciences Dr. Arnold Johnson, a well-recognized researcher for more than 20 years, is new to ACP. Dr. Johnson’s expertise in physiology and pharmacology provides an ideal fit for the expanding Department of Pharmaceutical Sciences. Dr. Johnson worked at the Stratton VA Medical Center in Albany for 20 years prior to joining the College and had been consistently funded by grants from the Department of Veteran’s Affairs and the National Institutes of Health. The grants supported his research in lung inflammation and septic shock. Presently, Dr. Johnson has a grant valued at approximately one million dollars from the National Heart, Lung and Blood Institute (NHLBI). His research is focused on improving the understanding of the molecular mechanisms that cause the organ dysfunction often associated with septic shock, a disease which ranks as one of the leading causes of death in hospital ICU’s. Dr. Johnson serves on the editorial board of the American Journal of Physiology and routinely participates in Study Sections for NHLBI and the American Heart Association. He has three students in his lab this semester working on lung biology, cell biology and cell biochemistry. He is in the process of applying for a five-year grant from NHLBI to continue his research. “Septic shock kills 250,000 people each year. It is the unpublicized disease.”
Catherine Sheffield, Pharm.D. Department of Pharmacy Practice Assistant Professor (Endocrine Group) Cathy Sheffield followed a different path into pharmacy compared to many of her colleagues. She graduated with a bachelor’s degree in biology from the University of Virginia, and decided to pursue a career in pharmacy only after spending two years as an assistant volleyball coach at UAlbany. She entered the accelerated program at ACP in 2003, graduating in 2006 with a 4.0 GPA. She followed with a residency at the Endocrine Group in Albany, satisfying her desire to work with both physicians and patients. While assisting students on their rotations, she realized she had an interest in teaching, and she joined the ACP faculty this past fall.
Johnson
Sheffield
Steiner
In addition to teaching and practicing, Dr. Sheffield is conducting clinically-based research on diabetes. Last summer she worked with hundreds of patients with diabetes to compare the performance of different blood-glucose meters. She presented a poster of her findings at the October meeting of the American College of Clinical Pharmacy and received third place in the resident/fellow poster competition. She is now preparing a manuscript on her research for publication. “In my job, I get to see patients myself and help train future pharmacists who will work with thousands of other patients. You feel like you are really making a difference.”
Alexandre A. Steiner, Pharm.D., Ph.D. Department of Pharmaceutical Sciences Assistant Professor of Pharmacology Alexandre Steiner believes in the power of combining teaching and research. He benefited from the fusion of these two disciplines initially as a student and then as a mentor. He joined ACP because it offers an environment that will allow him to further develop his research program with the participation of bright and dedicated students. Dr. Steiner’s area of expertise is in the body’s defense system. He studies the physiological strategies employed by the body to cope with systemic inflammation and infection, strategies such as fever versus hypothermia and behavioral excitation versus depression. His research seeks answers to questions such as:What clues determine the type of strategy used? How does the body interpret these clues at the molecular, cellular and systemic levels? Does the body ever fail to select the most appropriate strategy? If so, are there therapeutic ways to correct for such a failure? Dr. Steiner’s background includes Pharm.D. and Ph.D. degrees from the University of Sao Paulo, research scholarship at the University of Tennessee and postdoctoral training at St. Joseph’s Hospital in Phoenix, Arizona. In his young career, Dr. Steiner has already published nearly 50 articles in renowned peer-reviewed journals, in addition to having served as expert reviewer and guest editor to many journals. “It’s great for students to get into research. Familiarity with the scientific approach makes a more critical professional.”
Albany College of Pharmacy PRESIDENT’S REPORT 2007
Bachta
ACPPresRepFINAL
4/4/08
3:57 PM
Page 6
CO L L A B O R AT I O N P R O PA G AT I O N
ACP Sought as Research Partner
> ACP is one of 10 academic and biomedical research institutions collaborating as the Upstate New York Consortium for Health Care Research and Quality to raise the level and prominence of biomedical research in upstate New York. The consortium is coordinated by the Foundation for Healthy Living, an independent health services and research organization with offices in Latham and Buffalo. ACP is also a member of the Upstate New York Translational Research
Albany College of Pharmacy is strengthening its reputation as a strong and sought-after research partner and embracing the collaborative spirit that has emerged as a driving force in scientific discovery.
“Great discoveries and improvements invariably involve the cooperation of many minds.” — ALEXANDER GRAHAM BELL
Network, composed of the same 10 institutions as the consortium, but with a mission more tightly focused on facilitating and expanding clinical and translational research in upstate New York. Leon Cosler ’82, Ph.D, associate professor in the Department of Pharmacy Practice, coordinates ACP’s involvement in the consortium and sits on the executive committee. “In order to compete with large city collaborations for shrinking health and medical research funds, it became clear that we could all benefit from coordinating the work of the major health research institutions in upstate New York,” Dr. Cosler said. “Most federal monies are being granted not to single institutions, but to those who collaborate and can capitalize on the strengths of many players.” The consortium has several projects underway to augment and facilitate research among its members: streamlining the review process for research involving human subjects; creating a resource database of faculty research, and equipment to make it easier for fac-
ulty to find and collaborate with each other on grant applications and research projects; and establishing a computer system to enable faculty from different institutions to more easily work on and share large research files. Dr. Cosler is also director of the Research Institute for Health Outcomes (RIHO) at ACP, an interdisciplinary group of faculty that conducts collaborative research on health outcomes in a variety of clinical areas, health technology assessment and pharmacoeconomics. RIHO works closely with other research institutes including Albany Medical Center, the New York State Medicaid Drug Utilization Review Program and the Stratton Veteran’s Administration Medical Center. One of RIHO’s newest collaborations is with Medstat, the healthcare informatics division of Thomson Healthcare, which collects and integrates data from hospitals, outpatient clinics and pharmacies on the health care treatment experience of more than 40 million insured persons across the U.S. After recognizing the level of expertise within RIHO and the potential for valuable partnerships, Thomson representatives came to ACP in November for a day-long meeting to see how the two groups might work together on additional projects. “The relationship has already led to demonstrated outcomes: we have submitted one application for funding in HIV research and at least three more studies are in various stages of development,” says Dr. Cosler. “We are excited to team up with RIHO to offer innovative research solutions that address questions about our nation’s health care system,” says Stacey Long, vice president of client services for Thomson Healthcare. “Our database offers a strong foundation for a variety of health outcomes studies that RIHO may wish to conduct, and we hope to leverage the expertise of the RIHO staff in our own outcomes research services that we deliver to the pharmaceutical/biotech industry.”
ACPPresRepFINAL
4/4/08
3:57 PM
Page 7
P7
Albany College of Pharmacy PRESIDENT’S REPORT 2007
In order to compete with large city collaborations for shrinking health and medical research funds, it became clear that we could all benefit from coordinating the work of the major health research institutions in upstate New York. Most federal monies are being granted not to single institutions, but to those who collaborate and can capitalize on the strengths of many players. Patrick Meek, Pharm.D., assistant director of RIHO and an assistant professor in the Department of Pharmacy Practice, has been using Medstat data to look at the impact of a relatively new biologic therapy for Crohn’s Disease on hospitalizations, ER visits, outpatient office visits, and total health expenditures. He also plans to use Medstat data to assess the persistence of long-term maintenance therapies for Crohn’s disease and identify risk factors for nonadherence. Studies of drug persistence — the ability of patients to continue with a treatment regimen — involve looking at data of how long patients continue to get refills. His interest in inflammatory bowel disease stems from his interaction with patients at a pharmacy practice clinic he started while at the University of Wisconsin.“The degree of burden this disease places on patients is daunting. It usually hits them when they’re young — in college or just starting careers — and severely limits their achievement and productivity. Fortunately, recent advances in drug therapies have had a positive impact on patient outcomes.” The Pharmaceutical Research Institute (PRI), led by Shaker Mousa,
Ph.D., MBA, FACC, FACB, is also active in collaborative research efforts with academic institutions and pharmaceutical and biotechnological companies worldwide as it pursues new and better ways to solve medical questions. This year, PRI entered into contract negotiations with Hocus Locus, a bioinformatics company that got its start at the University at Albany’s Gen*NY*sis Center for Excellence in Cancer Genomics, located at the same Rensselaer, N.Y. facility that houses PRI. PRI wants to use the software developed by Hocus Locus to determine how genes are affected by proteins and learn more about resistance to chemotherapy as well as drugs that make cells more sensitive to chemo. “We want to see if we can better understand these genes to ultimately improve treatment for cancer patients,” Dr. Mousa says. PRI and the Ordway Research Institute, Inc., ACP’s neighbor in the University Heights district of Albany, are collaborating with the Cleveland Clinic and Roswell Park Cancer Center in Buffalo on novel U.S.-patented targets to fight glioblastoma, or brain cancer. This effort has tremendous potential in achieving new therapeutic modalities for brain cancer patients.
Dr. Mousa is also collaborating with Roswell Park on a National Cancer Institute grant to investigate the role of low molecular weight heparins (LMWH) and non-anticoagulant heparin (NACH) in enhancing the uptake of chemotherapeutic agents into lung or breast tumors and the decrease in deposition of tumor matrix that facilitates growth and metastasis. Collaborations with other academic and health care institutions have included those with Albany Medical College, Cornell University, Rensselaer Polytechnic Institute, the State University of New York at Buffalo, The Johns Hopkins University, University of Pennsylvania, University of Toronto, Stratton Veterans Administration Medical Center and the NYS Department of Health’s Wadsworth Center/David Axelrod Institute. In addition, PRI has workded with pharmaceutical and biotechnology companies that include Albany Molecular Research,Aventis Pharmaceuticals,Dupont Pharmaceuticals,Eli Lilly and Co.,Emisphere Technologies, Inc. GloxoSmithKline Inc., Johnson and Johnson, LEO Pharma, Merck & Co.,Inc.,Othera Pharmaceuticals Inc.,Pfizer Inc.and SelectX Pharmaceuticals among others.
ACPPresRepFINAL
4/4/08
3:57 PM
Page 8
SAVE TH E DATE
Albany College of Pharmacy
Nature-ceuticals Symposium June 14–15, 2008 Keynote Speaker: David M. Eisenberg, M.D. Director of the Division of Research and Education in Complementary Medicine at Harvard Medical School Special Event: Japanese Tea Ceremony presented by the headmaster of the Ueda Sokei school of tea
For more information visit:
www.nature-ceuticals.org or call
518-694-7123
ACPPresRepFINAL
4/4/08
3:57 PM
Page 9
P9
BRI DGI NG SCI ENCE AN D PRACTICE
Substances derived from natural products have been utilized to treat various medical conditions since the beginning of time. Now a grant from Maruzen Pharmaceuticals of Onomichi City, Hiroshima, Japan, will bring leading researchers in the field of natural products to ACP to share their expertise. > The theme of the inaugural Nature-ceuticals Symposium, scheduled for the weekend of June 14–15, 2008, is the bridging of the science and clinical practice, or application, of natural products. “Although a great deal has been learned about the chemistry of many natural products and a number of clinical trials are underway, it is often difficult for medical practitioners to access necessary information. Questions about dosage, contraindications, adverse drug interactions and pharmacokinetics are particularly difficult to answer,” said Dudley Moon, Ph.D., a professor of biological sciences at ACP who steered the planning process for the event. “The goal of the symposium is to bring scientists, clinicians and production personnel together to find answers to these questions.” The symposium’s title was coined to highlight its unique theme. “Herbals, natural products, nutraceuticals and phytomedicinals are just a few of the terms that have been used to describe this field of health care and each term has its own historical context and set of assumptions,” explained Dr. Moon. “The organizing committee wanted a fresh perspective and unanimously adopted the term Nature-ceuticals when it was proposed by Dean Mehdi Boroujerdi.” The symposium will lead off with keynote speaker David M. Eisenberg, M.D., the Bernard Osher Associate Professor of Medicine at Harvard Medical School and director of the Division of Research and Education in Complementary and Integrative Medicine. In 1979, under the auspices of the National Academy of Sciences, Dr. Eisenberg was the first medical exchange student from the United States to travel to the People’s Republic of China. In 1993, he was the medical advisor to the PBS series “Healing and the Mind” with Bill Moyers and has been a featured guest on PBS’ flagship public affairs series,“Frontline.” More recently, Dr.
Eisenberg has served as an advisor to the National Institutes of Health, the Food and Drug Administration and the Federation of State Medical Boards with regard to complementary, alternative and integrative medicine research, education and policy. Other highlights of the symposium will include breakout sessions on unique Japanese natural products as well as the clinical applications and chemistry of natural products. A special cultural feature will be a lecture and demonstration on the Japanese tea ceremony by the headmaster, or O-lemoto, of the Ueda Sokei school of tea. This particular style of tea ceremony is 350 years old and unique to the Hiroshima region of Japan. The symposium marks the first time the current headmaster will be presenting his style in America. Although the preparation and serving of powdered green tea, or matcha, was originally used primarily for medicinal purposes, over the centuries the tea ceremony became integrated with meditation and aspects of Zen Buddhism. The ceremony as practiced today is considered to be not only healthful but also an excellent way of calming and centering one’s self. Master Ueda agreed to participate in the symposium in memory of the late Higurashi, Akifumi, president of Maruzen Pharmaceuticals. The conference is in large part due to the efforts and initial funding provided by Mr. Higurashi and Maruzen, which has served as an experiential education site for ACP students for several years. Although he was unable to attend because of illness, Mr. Higurashi was awarded an honorary doctorate during ACP’s 2007 commencement. Sadly, he passed away in late May 2007. He is survived by his wife, a son and three daughters, some of whom will be in attendance at the symposium in June.
Albany College of Pharmacy PRESIDENT’S REPORT 2007
Inaugural Nature-ceuticals Conference to Explore the Science and Application of Natural Products
ACPPresRepFINAL
4/4/08
3:57 PM
Page 10
1 4 of every
CANCER =
DEATHS IN THE US
Second LEADING CAUSE OF DEATH after heart disease
ACPPresRepFINAL
4/4/08
3:57 PM
Page 11
P 11
Every one of us knows someone battling cancer or has lost someone to cancer. It is a disease that continues to impact the makeup of our society and the landscape of our health care system.
Albany College of Pharmacy faculty are leveraging some of the latest scientific and technological innovations to explore new approaches for cancer prevention, detection and treatment. The promise of this research has drawn the attention of organizations such as the National Institutes of Health and National Cancer Institute who are funding projects with ACP faculty in the hopes that their work may one day lead to a breakthrough in the ongoing battle against this insidious disease.
In 2007
CANCER CLAIMED AN ESTIMATED
MORE THAN
560,000
1.4 million
lives in the US
new cancer cases were diagnosed
Albany College of Pharmacy PRESIDENT’S REPORT 2007
A C P FA C U LT Y F I G H T B A C K A G A I N ST C A N C E R AT E V E RY STA G E
When Good Cells Go Bad
ACPPresRepFINAL
4/4/08
3:57 PM
Page 12
SITE-DIRECTED THERAPY Shaker Mousa, Ph.D., MBA, FACC, executive vice president and chairman of ACP’s Pharmaceutical Research Institute (PRI), has received several grants this year for nanopharmaceutical research, using particles 10,000 times smaller than a human hair to deliver drugs that will stop the spread of tumors and maximize the effectiveness of chemotherapeutic agents, while minimizing their notorious negative effects. A $406,400 grant from the U.S. Department of Defense has funded research to develop ways to use nanopharmaceuticals to deliver chemotherapeutic agents that target breast cancer cells. Such “site-directed therapy” will deliver the drugs to cancer cells only and limit the toxic effects to healthy cells. In addition, the National Institutes of Health (NIH) funded a collaborative effort between the United States and Egypt to research breast cancer, a disease prevalent in both countries. The project focuses on nanoparticle-targeting to increase the efficacy of anticancer drugs used to treat breast cancer, and also addresses the development of drug resistance. Another grant from the National Cancer Institute (NCI) involves two different nanoparticletargeting strategies to deliver a chemotherapeutic agent directly to breast tumors, as well as an agent that reduces the development of drug resistance. A second NCI grant was awarded this fall to explore a nanobiotechnology initiative to reverse resistance to chemotherapy. The strategy is based on sitedirected delivery of chemotherapy in combination with novel molecular targets to reverse chemoresistance and improve response of the tumors to the drugs. “Experimental studies like these will hopefully lead to the application of such nanotherapy regimens for the treatment of cancer in the future,” Dr. Mousa says. “These will greatly increase the efficacy of treatment modalities, as well as minimize any adverse effects.”
PRI researchers are using particles 10,000 times smaller than a human hair to deliver drugs that will stop the spread of tumors and maximize the effectiveness of chemotherapy.
Dr. Mousa and his research team also have developed non-anticoagulant heparin (NACH) compounds that may significantly impact one of the most deadly side effects of chemotherapy: blood clotting. Complications from blood clotting are the second most common cause of death among cancer patients, affecting 25% of those afflicted with the disease. Though patients are often treated with agents such as low molecular weight heparins (LMWH) to limit abnormal clotting, those agents have not proven as beneficial in breast cancer clinical trials. Dr. Mousa developed the new NACH compound to address the dose-limiting side effects of LMWH and improve the effectiveness of chemotherapy in breast cancer patients. Researchers at PRI are also working with hospitals and research facilities locally and across the nation to fight cancer — a prime example of the collaborative spirit that characterizes much of ACP’s research activities (see article on page 6).
N AT U R A L A N T I - C A N C E R A G E N T S Prashant Chikhale, Ph.D., an associate professor in the Department of Pharmaceutical Sciences, is also exploring ways to target, attack and destroy tumors by focusing on the discovery and development of new anti-cancer agents. A former pharmaceutical industry developer of drug delivery systems, Dr. Chikhale has recently been researching a natural product called acharan
ACPPresRepFINAL
4/4/08
3:57 PM
Page 13
P 13
Albany College of Pharmacy PRESIDENT’S REPORT 2007
sulfate that is extracted from the body of the African Giant Snail. This complex carbohydrate has shown promise in the labs, particularly in fighting brain tumor cells. “Understanding the properties of this novel natural agent will allow us to formulate it into a pharmaceutical product. Products obtained from nature generally tend to be less toxic. If this agent is found
to be efficacious in treating brain tumors, it will be of significant clinical value, because brain tumors are notoriously difficult to treat.” Dr. Chikhale, who has been collaborating on this project with Rensselaer Polytechnic Institute professor and researcher Dr. Robert Linhardt, hopes to eventually develop the agent into a pharmaceutical form that can be administered intravenously.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 14
Faculty work with fruit flies because of the ease with
U N D E R STA N D I N G T U M O R C E L L P R O L I F E R AT I O N
which their cells can be genetically manipulated.
As front-line professionals, community pharmacists have direct access to a huge number of patients and can provide information on cancer screening to them in the hopes of increasing early detection.
Jeffrey Voigt,Ph.D.,an associate professor in the Department of Pharmaceutical Sciences, is investigating ways to slow or stop the growth of tumor cells by finding new ways to trigger the tumorsuppressing Vitamin D Up-Regulated Protein (VDUP). He and select ACP students (see story pg. 28) are working with breast cancer cells in the lab to understand exactly how tumor cell proliferation is regulated. They are examining transcription factors — proteins that play a role in turning on and off genes and proteins — such as AP-1, which has a significant role in regulating the expression of other genes. An increase
in VDUP appears to decrease AP-1 activity, raising the question of whether VDUP can be used to regulate other transcription factors. Dr. Voigt and faculty member Richard Dearborn Jr., Ph.D., are working with fruit flies because of the ease with which their cells can be genetically manipulated. Once they identify the pathways that VDUP may be involved in, they can then determine whether breast cancer cells have the same pathway, and if so, whether they react the same. Another subject of study has to do with the transport of VDUP from its site of synthesis in the cytoplasm to
ACPPresRepFINAL
4/4/08
3:58 PM
Page 15
P 15
Albany College of Pharmacy PRESIDENT’S REPORT 2007
the nucleus, where it appears to act. Dr. Voigt is studying whether phosphorylation, a process by which a phosphate group is added to proteins, may regulate how much VDUP is transported into the nucleus, and if so, how to manipulate that. “Our hypothesis is that if we can find a way to manipulate the levels of VDUP in tumor cells to very high levels, we could slow or even stop their growth.”
PAT I E N T T R E ATM E N T A N D CO U N S E L I N G
Sarah Scarpace, Pharm.D., BCOP, assistant professor in the Department of Pharmacy Practice, together with ACP students, works directly with cancer patients at Albany’s Stratton VA Medical Center’s oncology clinic to develop chemotherapy regimens and counsel patients about side effects that may occur. When patients return for subsequent cycles, Dr. Scarpace and her students perform toxicity assessments — interviews to determine what side effects were experienced — and recommend changes in their regimen or supportive care if necessary. They also
perform medication reconciliations, comparing what patients are really taking with what is documented in their charts. “Students have the opportunity to apply all the knowledge they’ve gained in five years to real people. They get to work directly with cancer patients, under my supervision, and in doing so, help impact their treatment and quality of life.” By providing continuing education sessions for community pharmacists, Dr. Scarpace also helps them identify ways to provide information on cancer screening to patients in the hopes of increasing early detection. “It’s an ideal place to provide that kind of education, because, as front-line professionals, community pharmacists have direct access to so many patients,” she says. She also has created an elective course on cancer screening and early detection, and helped found a Colleges Against Cancer chapter at ACP, where students work in four strategic areas to educate the community about cancer screening and the importance of early detection.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 16
E CO N O M I C I M PA C T Leon Cosler ’82, Ph.D., an associate professor in the Department of Pharmacy Practice, has researched the pharmacoeconomics of a genetic test that can help determine the risk of breast cancer recurrence and guide treatment decisions. If breast cancer is caught early enough, the treatment is relatively specific: surgery to remove the tumor and primary treatment. But then the patient has a difficult decision to make about long-term treatment to prevent its recurrence. That decision has typically been based on the size of the tumor, protein markers that may help predict how aggressive the tumor is, whether the cancer has invaded neighboring tissue — if this can be determined — and the physician’s experience. Getting it wrong can be costly. If you treat the cancer moderately using a single, relatively benign drug over time, the cancer may recur elsewhere and require aggressive — and expensive — treatment. If you opt for intensive chemotherapy in hopes of preventing recurrence, you also need to treat the toxic side effects of this risky and expensive treatment.
Now there are genetic tests on the market that can determine the risk of cancer recurrence and help patients to make better treatment decisions.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 17
P 17
Working with oncologists from the University of Rochester and Stanford University, Dr. Cosler found that use of the Oncotype DX TM in women with early stage breast cancer resulted in savings of about $2,200 per year of life saved, which averaged two years per patient, compared to traditional “best-guess” therapies — in other words, longer life expectancy with more manageable costs. The team’s research was published in the peerreviewed journal Cancer in March,and as a chapter in the book Translational Therapeutic Strategies in Breast Cancer, published by Informa Healthcare (London, 2007). “This is an excellent example of the value of diagnostic testing as well as pharmacoeconomics in determining the cost-effectiveness not only of new drug therapies, but any new medical test or technology.”
From a public health perspective, helping people to stop smoking is one of the most significant things we can do.
S M O K I N G C E S S AT I O N Working closer to the origins of the problem are dedicated professionals seeking to prevent cancer cases. Nicole Stack Lodise ’02, Pharm.D., assistant professor in the Department of Pharmacy Practice, is working to reduce the number of people who die from cancer related to tobacco use — more than 180,000 each year in the U.S. alone — by helping people quit smoking. She is one of the coordinators of a tobacco cessation service for inpatients at Albany Medical Center, where she is a clinical pharmacist in the Women’s Health Clinic. What began as a pilot program to help a target group of inpatients and employees quit smoking (the hospital became tobacco free on January 1, 2007) was expanded to provide all inpa-
tients with tobacco cessation education, counseling and support on a referral basis as part of a patient’s plan of care. “The next step is to evaluate the efficacy and impact of this service,” Dr. Lodise says. “Are we reaching all the patients that we need to? Is our model effective in helping patients quit? How do outcomes compare to similar programs around the country?” “There is growing information on the number of cancer types that have a direct or contributory link to tobacco use. From a public health perspective, helping people to stop smoking is one of the most significant things we can do.”
Albany College of Pharmacy PRESIDENT’S REPORT 2007
But now there are genetic tests on the market that can determine the risk of recurrence. One, called Oncotype DX TM Breast Cancer Assay, is a DNA test using a set of 21 genes chosen for their predictive abilities to quantify a tumor’s risk of recurrence and assess the potential benefit from chemotherapy. The test is remarkably accurate in its ability to inform the patient of the likelihood of recurrence. By identifying in advance those most likely to benefit from chemotherapy, as well as those who are unlikely to benefit, the test can help women make individual treatment decisions and avoid the toxic effects of a chemo regimen that is unlikely to be successful. “The treatment of cancer is expensive enough. This test enables patients to make better — and more cost-effective — decisions about treatment options,”Dr. Cosler says.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 18
D I A G N O ST I C T E C H N I Q U E S A N D T R A I N I N G
When cancer does strike, the first step in fighting back is an accurate diagnosis. Indra Balachandran, Ph.D., SCT, CFIAC, is working to improve diagnostic techniques and training ACP students to become expert cytotechnologists. “Clinicians rely on our diagnosis — which we make with the help of pathologists — along with other findings to decide on the best treatment for the patient,” says Dr. Balachandran, director of the cytotechnology program in the Department of Health Sciences at ACP. She works with students to analyze cellular samples from various body sites and to locate and interpret various diseases, including precancerous conditions and cancer. She then helps the students arrive at correct diagnoses and classify the type of cancer, an important consideration in deciding the appropriate therapy for the patient. Dr. Balachandran is working on a grant from MonoGen, Inc. to build an archive of fine needle aspirations utilizing a liquid-based preparation method recently approved by the FDA called MonoPrep. Because the MonoPrep test is new, few examples of fine needle aspiration cytomorphologic patterns from different types of malignancies and other benign pathologic conditions exist.
Dr. Balachandran is identifying and preparing a collection of this material from different samples that will provide practitioners with an atlas to guide future diagnoses and ultimately help to save lives.
From the bench to the bedside, ACP faculty and researchers are pursuing innovative approaches to help improve the way cancer is diagnosed and treated. As the College continues to expand its research capabilities and delves deeper into pharmaceutical sciences and biomedical technology, the myriad ways in which ACP can make an impact in understanding cancer and other diseases will only continue to increase.
>
During the writing of this article, the author’s closest aunt succumbed to cancer. She was 65. This article is dedicated to Miriam Helene Dyson, 1942–2007, and all those loved ones lost to cancer. “It is with profound gratitude that I learn of and share the amazing research efforts and work of these ACP faculty in the prevention and treatment of this terrible disease.” —SHANNON BALLARD GORMAN
ACPPresRepFINAL
4/4/08
3:58 PM
Page 19
P 19
Albany College of Pharmacy PRESIDENT’S REPORT 2007
Water, Water Everywhere
Leonardo da Vinci said that “water is the driving force of all nature” but for four Albany College of Pharmacy faculty members, the words could apply to their research as well. In very diverse ways, water has been a unifying theme of their work, both on- and off -campus, over the past several years. >
ACPPresRepFINAL
4/4/08
3:58 PM
Page 20
K I N G D O M S O F WAT E R
Dr. d’Oney at Lake Itasca, source of the Mississippi River.
He’s lived all over the world, but J. Daniel d’Oney, Ph.D., has gone back to his Louisiana roots when it comes to his research. His subject of choice these days is the United Houma Nation, a group of Native Americans who now reside to the south of New Orleans. An assistant professor in the Department of Arts and Sciences, Dr. d’Oney teaches several courses on Native Americans at ACP. With the help of a Scholarship of Discovery Grant from the College for the 2007–2008 academic year, he spent the dog days of summer in his home state researching a new book, Kingdoms of Water: A History of the Houma Nation. His work will result in the first comprehensive history of the tribe. “I’ve titled the book thus for a couple of reasons,” says Dr. d’Oney.“The Houma have always lived on or near water and, just like water, they have shifted and adapted over time.” The Houma first were documented in 1682 living on the Mississippi near the mouth of the Red River. Over the years, they relocated several times, moving downstream to Bayou St. John, just outside New Orleans, and then back upstream to a site south of modern-day Baton Rouge. As a result of shifting politics and pressure from Acadians arriving from Canada, the Houma relocated once again in the late 1700s, this For his research, time southward to the isolated bayDr. d’Oney lived near ous of Lafourche and Terrebonne Houma settlements and parishes, where they live today. “I first met members of the talked to literally United Houma Nation when I was hundreds of an undergrad but really started to work with them when I did a graduHouma Indians. ate internship with the Louisiana Division of Archaeology,” explains Dr. d’Oney, who subsequently based his Ph.D. dissertation at Arizona State University on the Houma people. For his research, Dr. d’Oney lived near several Houma settle-
Below: Many trees have died as salt water infiltrates the coast of Louisiana. The Houma once lived in this area before hurricanes drove them inland. Right: Shrimp boat leaving the Houma community of Dulac, La., to head down the Mississippi.
Daniel d’Oney
ments and talked to literally hundreds of Houma Indians. His fluency in French, which replaced the Houma language in the late 1800s, and his knowledge of the hunting, trapping and fishing that were the basis of the Houma economy for many years, have gone a long way toward forging bonds with the tribe. He has also put in many hours among primary sources in French, Spanish and American archives. Water remains a huge influence on the contemporary Houma Nation. Coastal erosion is a big problem, impacting major food sources. And Hurricanes Katrina and Rita had a devastating effect on the tribe. “Rita was actually much worse for the Houma as they were on the eastern side of the hurricane, which is always the worst due to storm surge patterns,” explains Dr. d’Oney. “Water was dumped in houses that had already lost their roofs from Katrina.” Relief efforts were complicated by the fact that the Houma Nation is not officially recognized by the Bureau of Indian Affairs and has no government representation. Dr. d’Oney’s research theme continues. His article “Watered by Tempests: Hurricanes in the Cultural Fabric of the United Houma Nation” recently has been accepted by the American Indian Culture and Research Journal and is set for publication in May 2008.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 21
P 21
John Polimeni and Ray Chandrasekara
You definitely could say “a river runs through” the research of two ACP faculty members whose work is linked by a common theme of water. With a strong research interest in ecological economics, Assistant Professor John Polimeni, Ph.D., of the Department of Pharmacy Practice has collaborated with Ray Chandrasekara, Ph.D., an assistant professor in the Department of Arts and Sciences, to publish the article, “Water, Development and State Security in South Asia: Scenarios for China and India,” which appeared in Reconstruction: Studies in Contemporary Culture. Dr. Polimeni, who teaches courses from the economics of health care to econometrics at ACP, has meshed his own interests with Dr.Chandrasekara’s focus on Asia and bioethics in the developing world to create a great partnership. “Ray has a broad knowledge of Southeast Asia and is very in tune with geopolitical, health and water issues,” says Dr. Polimeni. “Our work is the very definition of transdisciplinary. Few academic fields are isolated these days — economics affects the environment, policies, and so on.” Their research explored the geopolitical aspects of water in a changing world. Though conflict over water has not occurred for thousands of years, the dynamics of contemporary South Asia are changing so rapidly that a conflict at some point in the future may be unavoidable according to the duo. Water shortages have the potential to cause famine, political instability and diminished economic growth, fomenting territorial disputes and global instability. “Water and natural resources may cause the next great war,” Dr. Polimeni says. “Water can be a real driver for conflict,” says Dr. Chandrasekara. Many insular Southeast Asia cultures are heavily dependent on rivers which provide food, fertile silt, transportation and water. When that water supply is cut off, the trouble begins.
In China, for instance, there are nearly 26,000 large dams — more than any other country in the world. Dams — “so big they can be seen from outer space” — are preventing the flow of water downstream to small countries such as Vietnam and Thailand, allowing China to garner more political influence in the region, according to Dr. Polimeni. After publishing their findings in the International Journal of Interdisciplinary Social Sciences and International Journal of Transdisciplinary Research, the pair has returned to some solo research in their chosen fields with the assistance of funding from ACP. Dr. Polimeni received an Educational Excellence Grant for curricular development of the Economics of Health Care course at ACP while Dr. Chandrasekara used a Scholarship of Discovery Grant for his work on Malaysian and Indonesian literature.
The Three Gorges Dam in China is one of nearly 26,000 large dams in the country.
Albany College of Pharmacy PRESIDENT’S REPORT 2007
A RIVER RUNS THROUGH IT
ACPPresRepFINAL
4/4/08
3:58 PM
Page 22
OV E R T H E B O U N D I N G M A I N Ken Blume, Ph.D.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 23
P 23
Albany College of Pharmacy PRESIDENT’S REPORT 2007
These classes help students to broaden their focus to include issues, not only in the contemporary health care environment, but in the world.
While other faculty members are involved in research that centers around rivers, Ken Blume has focused primarily on salt water. Since receiving his Ph.D. in American history with concentrations in American and Atlantic maritime history, the bulk of his work has been “seaworthy” in nature. “In the 21st century, people tend to forget how intimately this country is connected to the sea,” says Dr. Blume, a professor in the Department of Arts and Sciences.“We’ve been tied to the sea since our earliest history.” Dr. Blume has been particularly busy of late with two books forthcoming: Advancing American Sea Power: The Story of Richard W. Meade, 1837–1897 and the Historical Dictionary of the U.S. Maritime Industry. He is also working on a profile of the U.S. Naval Officer corps in the decade prior to the Civil War. Dr. Blume received a Scholarship of Discovery grant from ACP during this academic year for his work on African-Americans in the U.S. diplomatic corps between 1865 and 1914. “U.S. foreign relations and foreign policy were very much tied to sea power during this time,” he says. Early American economic growth springs largely from its seas and rivers, Dr. Blume explains. Nineteenth century industrialization had its birth on the water and, within the country, maritime developments such as rivers and canals fueled internal economic development. In addition, the slave trade was a major component of the American maritime industry, and even after it
was outlawed in 1808, the illegal trade continued and made many Americans, including Northern entrepreneurs, wealthy. “The maritime industries were really America’s first multi-national businesses,” Dr. Blume says. “They illustrate the relationship between the government and business as well as linkages between the private and public sectors.” “Even today, the sea is still the most cost-efficient method of transportation we have. Our dependence on the importation of oil demonstrates the importance of maritime transportation,” says Dr. Blume, who goes on to say that the U.S. probably imports three-quarters of its critical commodities, such as platinum, ferrochrome and oil, by ship. Dr. Blume’s work has been invaluable to the courses he teaches at ACP, including those in American Foreign Policy, the Civil War and International Relations. ACP students in the first two years of the curriculum, whether in the Pharm.D. or the Bachelor of Science programs, are required to take courses in a liberal arts core that encourages personal intellectual growth and a sense of professionalism. Many students continue to avail themselves of humanities electives up through their fifth year. “These classes expand the students’ historical, cultural, literary, scientific and philosophical perspectives,” Dr. Blume says. “They help students to broaden their focus to include issues, not only in the contemporary health care environment, but in the world.”
ACPPresRepFINAL
4/4/08
3:58 PM
Page 24
AN D MOR E WATER >
Michael Dobis ’08 Dives Into Water Quality I T ’ S B E E N C A L L E D T H E ST U F F O F L I F E B U T I N S O M E C A S E S , T H E ST U F F I N WAT E R A C T UA L LY C A N B E H A R M F U L .
An internship last spring in New York State’s Office of the Attorney General (OAG) provided sixth-year Pharm. D. student Michael Dobis ’08 with an opportunity to research water quality issues stemming from the disposal of overthe-counter and prescription drugs. The unique internship resulted from a relationship forged by faculty members John Polimeni, Ph.D., and Leon Cosler ’82, Ph.D., who are engaged in ongoing work with the OAG. Michael presented the ACP team’s research findings in August at the Northeast Water Science Forum’s Pharmaceuticals and Personal Care Products: State of the Science conference in Portland, Maine. “Faculty-student research collaborations are win-win situations,” Dr. Polimeni says.“Faculty members work with eager assistants, who often bring new ideas to the project. Students gain the opportunity to conduct high-level research and learn skills that will set them apart from
ibuprofen, estrone and caffeine, have been found in the New York City watershed, the world’s largest water supply system. And because contaminated waters have been shown to adversely affect the animals in aquatic environments, that’s a real concern for humans too. There are several ways for pharmaceuticals to gain entry into water systems, including medications excreted by both livestock and humans that can work their way into nearby watersheds through runoff or public sewer systems. Additionally, says Michael, patients and health care workers sometimes dispose of unused or expired medications down a sink or toilet, from whence they are transported to a municipal sewer plant. Unfortunately sewage treatment plants are not designed to remove these complex synthetic chemicals, which eventually end up in reservoirs. Michaels’s presentation at the forum, which was organ-
There are many interesting and valuable ways one can have an impact on the world with a degree in pharmacy. their colleagues. And the entire ACP community benefits as a result of closer ties between students and faculty and increased recognition for the College.” “Michael was really enthusiastic about working in the attorney general’s office,” says Bill Millington, Ph.D., chair of the Department of Pharmaceutical Sciences. “He sets a great example for other students by demonstrating that there are many interesting and valuable ways one can have an impact on the world with a degree in pharmacy.” Michael’s research was certainly of interest to the folks in the OAG. According to a 2006 study by the New York State Department of Health, pharmaceuticals, including
ized by the New England Interstate Water Pollution Control Commission, weighed the pros and cons of several different solutions to the problem and the associated costs of each. In tandem with Drs. Cosler and Polimeni, he developed an economic model designed to reduce the presence of pharmaceutical products in the environment. “The economic perspective is a new take within a relatively new and emerging scientific field,” says Michael, who presented the group’s research to about 200 scientists, academics, industry leaders and regulatory representatives, including many of the top figures in the field. “It was pretty exciting and a great way to network,” Michael enthusiastically explains. “I gave my presentation just after one given by the former head of research for Pfizer.” In January, Michael’s abstract was selected by the Commission on Independent Colleges and Universities for their first Undergraduate Research Exposition. The Albany event brought together college students, faculty and New York State legislators to share the students’ research experiences. His research project was one of only 70 chosen statewide. The team is currently incorporating feedback from the conferences and working to improve their model. They hope to publish their results in the near future.
Michael Dobis developed an innovative economic model designed to solve a pharmaceutical problem.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 25
P 25
Albany College of Pharmacy PRESIDENT’S REPORT 2007
AN ELECTRIFYING EXPERIENCE
Lisa Murphy ’09 Lands Prestigious Fellowship Lisa Murphy had an eye-opening summer; following her sophomore year at ACP she was selected to participate in the prestigious and competitive Summer Fellowship Program at the Masonic Medical Research Laboratory (MMRL) in Utica, N.Y. Her experience at the lab has helped inspire her to pursue a research career. Currently a junior pharmaceutical sciences major, Lisa accepted the fellowship to see whether she “had an eye for research.”With a mixture of pride and humility, she reflects back on her experience, which involved 10 weeks of hands-on, cellular electrophysiology research. More specifically, she studied acidosis and its effect on sodium channels in the heart under the mentorship of Jonathan Cordeiro, Ph.D., a research scientist in experimental cardiology at MMRL. Acidosis occurs in the heart during conditions of ischemia induced by insufficient oxygen supI will be more than prepared for ply to the heart. This irregularity also may cause cardiac arrhythmias. Lisa’s my fourth year of independent studies involved patch clamping, research in the B.S. program which is designed to detect the elecalong with this year’s study in trical current moving in and out of cells. During the fellowship, Lisa pathophysiology. This fellowship gained a better understanding of dishas given me some different ease examination, in addition to experiencing the functions of a stateperspectives in how far you of-the-art research laboratory. “I may not necessarily go on to can take something. be an electrophysiologist, but I gained a much better understanding of the role basic research plays in the development of clinical applications as result of this fellowship,” Murphy said. “I will be more than prepared for my fourth year of independent research in the B.S. program along with this year’s study in pathophysiology. Now I can confidently say that I would like to pursue a career in research, more specifically research management.”
The MMRL is an internationally renowned medical research and educational institute dedicated to studies of the electrical activity of the heart. MMRL scientists have uncovered the mechanisms responsible for many forms of life-threatening cardiac arrhythmias as well as the mechanisms by which some drugs act to precipitate arrhythmias. In recent years, they have delineated the genetic basis for several inherited sudden cardiac death syndromes and become a central hub for genetic screening of inherited arrhythmic diseases in the United States. The fellowship program, initiated in 1960, provides an opportunity for undergraduate students of biology, physiology, biochemistry, medicine and other life sciences to participate in research under staff guidance. Last year, the program accepted just 10 students from approximately 50 applicants. “This fellowship has given me some different perspectives in how far you can take something. There are always going to be more questions you can ask and hopefully answer yourself. I think I will be asking myself and others a lot more questions in the future. Now I know that it is perfectly fine to ask question after question because that is what the people at MMRL are doing for a living.”
ACPPresRepFINAL
4/4/08
3:58 PM
Page 26
Research Activities Do Not Break for Summer ST U D E N T S A N D FA C U LT Y CO N T I N U E P U R S U I T O F L A B O R ATO RY B R E A K T H R O U G H S
Research, both in the laboratory and in clinical and community settings, is an integral part of the educational experience at Albany College of Pharmacy. Students have the opportunity to hone critical skills such as problem solving, data analysis and scientific reporting and faculty gain much-needed assistance, as well as a fresh perspective,from the students that they mentor.
Each summer the Student Summer Research Award Program, administered by ACP’s Office of Grants Administration, awards internships that provide a $2,000 stipend plus dormitory housing to students in any of the degree programs at the College. This past summer, seven students from the Bachelor’s in Pharmaceutical Sciences (BSPS) program and one Pharm.D. student participated in the highly competitive, eight-week program. “The program provides the opportunity for students to work with our talented faculty researchers — some of whom are internationally known in their respective areas,” says George Bailie, Pharm. D., Ph.D., associate dean of research and graduate education. “Some of the awardees also significantly contribute to research manuscripts, articles and abstracts that are subsequently published or presented at national and international meetings.” BSPS students Alex Villanueva ’09 and Joshua Marlow ’10 worked with Assistant Professor Carlos Feleder, M.D., Ph.D., in the area of septic shock, which results in an estimated 200,000 deaths in the U.S. each year. Alex presented an alternative view of septic shock, caused by an overwhelming infection of the blood stream that leads to severe inflam-
ACPPresRepFINAL
4/4/08
3:58 PM
Page 27
P 27
Albany College of Pharmacy PRESIDENT’S REPORT 2007
Left: Alexandra Rehfus ’09 focused her research with Robert Levin, Ph.D., on the treatment of interstitial cystitis. Right: ACP’s summer research awardees and their mentors presented their findings at a fall symposium at the College. Above: The high school research program included visits to local research facilities including Regeneron.
The program provides students the opportunity to work with talented faculty researchers.
mation and organ failure. Josh investigated the role of the central nervous system in lipopolysaccharide (LPS) hypotension during septic shock. Working with Dr. Feleder at the Stratton VA Medical Center, the students hope their work will lead to new strategies for treating this deadly condition. Florian Radu ’10 did research alongside Professor Robert Levin, Ph.D., on the effect of estrogen therapy on bladder function. Tasmina Hydery ’10 and Alexandra Rehfuss ’09 assisted Dr. Levin in his research on the role of alpha lipoic acid and coenzyme-Q, a natural anti-oxidant produced in the body, on the bladder. Now in her third year in the BSPS program, Alexandra has participated in the research program with Dr. Levin for the past two summers. “Our results showed that alpha lipoic acid and, even more so, a combination of it with coenzyme-Q, had a protective effect on the bladder,” says Alexandra, who explains that their work is focused on the treatment of interstitial cystitis. Shaarika Sarasija ’09 spent a second summer in the program to continue her research with Associate Professor Jeffrey Voigt, Ph.D., on vitamin D3-upregulated protein-1 (VDUP-1) and its role in the suppression of breast cancer. Shaarika assisted Dr. Voigt in his work to find new ways to trigger VDUP-1 in order to slow or stop the growth of cancer cells (see cover story, page 11.) In a continuing research project with Assistant Professor Adwoa Nornoo, Ph.D., Pharm.D. student Scott Beeman and third-year Pharm.D. student Aniwaa Owusu Obeng researched ways to increase the permeability of the chemotherapy agent paclitaxel in order to develop an oral formulation of the drug. Using colon cancer cells, the students tested to see what percentage of the drug passed through the cell membrane.
“The Summer Research Program was an amazing opportunity for me,” says Scott. “I actually got to perform the experiment rather than just watching my mentor.” In addition to the program for ACP students, for the past eight years the College has sponsored a summer research program for local high school juniors and seniors. “The program is designed to introduce high school students to the broad spectrum of careers in the pharmaceutical sciences,” says David Clarke, Ph.D., the director of the program and chair of the Department of Arts and Sciences at ACP. This past summer, a total of six students from Albany, Troy and Guilderland High Schools participated in the sixweek program, spending their days involved in laboratory research, drug discovery lectures, literature reviews and field trips to facilities including Albany Molecular Research, Covidien (formerly Tyco Healthcare/Mallinckrodt Pharmaceuticals), Albany Medical Center research facilities and Regeneron Pharmaceuticals. Martha Hass, Ph.D., supervised seniors Joseph Morris and Qualasia Parker in their research project “Synthesis of a Carbonate Adduct of Lipoic Acid and α-Tocopherol: An Antioxicidant for Treating Ischemia.” Troy High students Israel Powell and Alexandra Pirella worked with Arnold Johnson, Ph.D., to do a comparison of BCA and Bradford protein assays. Pharmaceutical Research Institute Executive Director Shaker Mousa, Ph.D., worked with Jake Valentine and Meera Chappidi on the analysis of a novel antioxidant and beta receptor for several different nanoparticles. ACP faculty lecturers included Dr. Hass on drug discovery and Dr. Nornoo on pre-formulation/formulation as well as Leon Cosler ’82, Ph.D., on post-approval monitoring. Angela Sheehan, R.N., director of clinical research administration at Albany Medical Center, presented on clinical trials.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 28
Undergraduate Research
Legislative Session ST U D E N T R E S E A R C H S H O WC A S E D F O R N E W YO R K STAT E L AW M A K E R S
Two ACP students had an opportunity to present their research at the Legislative Office Building in Albany in January 2008 at the inaugural Undergraduate Research Exposition sponsored by the Commission on Independent Colleges and Universities. The expo brought together college students, faculty and New York State legislators to share the experiences of stu-
Efforts to understand the complexities of human brain development and cancer benefit from studies of simpler organisms such as fruit flies.
dents engaged in research and scholarship. The event showcased the research of 70 student teams from 28 private colleges in New York State. Pharm.D. student Michael Dobis ’08, working with faculty members John Polimeni, Ph.D., Leon Cosler ’82, Ph.D. and Ray Chandrasekara, Ph.D., presented findings on water quality issues stemming from the disposal of over-thecounter and prescription drugs (see full article page 24). Third-year pharmaceutical sciences student Neil Mandalaywala shared his research on the tumor suppressor VDUP-1 (vitamin D3 up-regulated protein 1), which is inactivated in many cancers. His work with Assistant Professor Richard Dearborn Jr., Ph.D., found that VDUP-1 participates in brain development in both fruit flies and humans — observations that identified new ways to control expression of this anti-cancer protein. Randall Snyder ’09 and Solomon Chang ’11, both Pharm.D. students, co-authored the paper. Neil also presented
their
research in the fall at the Cold Spring Harbor Laboratory (CSHL) in Long Island.
Internationally
renowned,
CSHL researches cancer, neurobiology, plant genetics and bioinformatics and is one of 63 institutions supported by the Cancer Centers Program of the National Cancer Institute.
Neil Mandalaywala presented his findings at the Undergraduate Research Expo at the Legislative Office Building in Albany.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 29
P 29
> Research is an integral part of the faculty experience in every department at ACP as well as at the Pharmaceutical Research Institute. The Scholarly Activity report includes faculty publications, abstracts, presentations and grant activity for the period July 1, 2006 through June 30, 2007.
Albany College of Pharmacy PRESIDENT’S REPORT 2007
Scholarly Activity
ACPPresRepFINAL
4/4/08
3:58 PM
Page 30
Scholarly Activity
Pharmaceutical Research Institute
P U B L I C AT I O N S
GRANTS
Mousa SA, Feng X, Xie J, Du Y, Hua Y, He H, O’Connor L and Linhardt RJ. Synthetic oligosaccharide stimulates and stabilizes angiogenesis: Structure-function relationships and potential mechanisms. Journal of Cardiovascular Pharmacology 48(2):6-13, August 2006.
PROJECT: Evaluate the pharmacological activity of SelectX compounds in a panel of in vitro assays SPONSOR: SelectX TOTAL GRANT: $15,360 PROJECT PERIOD: 1/07-1/08
Mousa SA. Role of current and emerging antithrombotics in thrombosis and cancer. Timely Topics in Medicine: Cardiovascular Diseases 10:E19, August 2006. Murugesan S, Mousa S, Vijayaraghavan A, Ajayan PM and Linhardt RJ. Ionic liquid-derived blood-compatible composite membranes for kidney dialysis. Journal of Biomedical Materials Research: Part B, Applied Biomaterials. 79(2):298-304, November 2006. Mousa SA, Davis FB, Mohamed S, Davis PJ and Feng X. Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model. International Angiology 25(4):407-413, December 2006. Mousa SA, Linhardt R, Francis JL and Amirkhosravi A. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin. Thrombosis and Haemostasis 96(6):816-821, December 2006. Mousa SA. In-vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists and thrombolytics on platelet/fibrin-mediated clot dynamics in human whole blood using thrombelastography. Blood Coagulation and Fibrinolysis 18(1):55-60, January 2007. Puskás A, Balogh Z, Hadadi L, Imre M, Orbán E, Kósa K, Brassai Z and Mousa SA. Spontaneous recanalization in deep venous thrombosis: A prospective duplex ultrasound study. International Angiology 26(1):53-63, March 2007. Powell J and Mousa SA. Mechanisms of cytokine- and chemokinemediated angiogenesis. Journal of Cellular Biochemistry 12, March 2007 [Epub ahead of print]. Murugesan S, Mousa SA, O’Connor LJ, Lincoln DW II and Linhardt RJ. Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Letters 581:1157-1160, 2007. Hantgan RR, Stahle MC, Connor JH, Connor RF and Mousa SA. Paradoxical alpha(IIb)beta(3) priming and clustering by orally active and intravenous integrin antagonists. Journal of Thrombosis and Haemostasis 5(3):542-550, March 2007. Mousa AS and Mousa SA. Cellular effects of garlic supplements and antioxidant vitamins in lowering marginally high blood pressure in humans: Pilot study. Nutrition Research 27(2):119-123, 2007. Smiley S, Wong MKK and Mousa SA. Methods for monitoring of the anti-angiogenic activity of agents in patients: Novel trial design in Angiogenesis Assays (Carolyn Staton, et. al., eds.), Wiley, Chapter 18:115123, 2007. Alizadeh H, Al-Tajer S and Mousa SA. Hemostatic state in lung cancer patients: Pilot study. International Journal of Cancer Prevention 2(4), 2007 Cloonan ME, DiNapoli M and Mousa SA. Efficacy of anticoagulants and platelet inhibitors in cancer-induced thrombosis. Blood Coagulation and Fibrinolysis 18(4):341-5, June 2007. Davis PJ, Davis FB, Lin HY, Bergh JJ, Mousa SA, Hercbergs A, Fenstermaker RA and Ciesielski M. Cell-surface receptor for thyroid hormone and tumor cell proliferation. Expert Review of Endocrinology and Metabolism 1(6):753-761(9), November 2007. Mousa SA, Goncharuk O and Miller D. Recent advances of TNF-alpha antagonists in rheumatoid arthritis and chronic heart failure. Expert Opinion on Biological Therapy 7 (5):617-25, May 2007. Mousa SA. Angiogenesis and myogenesis in Textbook of Interventional Cardiovascular Pharmacology (Nicolas Kipshidze, et. al., eds.), Informa Healthcare, Chapter 34:393-405, June 2007. Mousa SA. Pharmacology of blood constituents in Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays (Vogel HG, Hock FJ, Maas J and Mayer D, eds.) Springer: Heidelberg, Germany, Chapter I.M.:255-318, 2007. Mousa SA and Ahmad S. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia. American Journal of Hematology 82(4):276-282, April 2007. Mousa SA, O’Connor L, Rossman TG and Block E. Pro-angiogenesis action of arsenic and its reversal by selenium-derived compounds. Carcinogenesis 28(5):962-967, May 2007.
PROJECT: Generation of PQQ conjugation polymers and physicochemical characterization and initial stability assessment SPONSOR: Charitable Leadership Foundation Medical Technology Acceleration Program TOTAL GRANT: $125,000 PROJECT PERIOD: 10/05-9/06 PROJECT: Role of 1, 6 Anhydo in Enoxaparin fractions in the modulation of endothelial tissue factor pathway inhibitor SPONSOR: Aventis TOTAL GRANT: $100,000 PROJECT PERIOD: 6/06- 05/07 PROJECT: Evaluations of anti-angiogenesis thyroid hormone antagonists in cancer models SPONSOR: Charitable Leadership Foundation Medical Technology Acceleration Program TOTAL GRANT: $231,250 PROJECT PERIOD: 9/05-4/07 PROJECT: Potential anti-angiogenesis efficacy of Othera’s novel antioxi-
dants
SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $24,000 PROJECT PERIOD: 10/05-11/06 PROJECT: Anti-angiogenesis efficacy and mechanism(s) of Othera’s novel antioxidant, TPH, and its impact on the anti-angiogenesis efficacy of potential strategies for ocular neovascularization-mediated disorders in human endothelial 3-dimensional sprouting model SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $57,600 PROJECT PERIOD: 10/05-7/06 PROJECT: Assay of iron and sucrose in samples SPONSOR: Genix Pharma, Ltd. TOTAL GRANT: $28,537 PROJECT PERIOD: 12/31/06-on-going PROJECT: Generation of tetrac conjugate polymers, physiochemical characterization and initial stability assessment SPONSOR: Charitable Leadership Foundation Medical Technology Acceleration Program TOTAL GRANT: $125,000 PROJECT PERIOD: 1/06-4/07 PROJECT: Anti-angiogenesis efficacies of TransMolecular lead TM601 SPONSOR: TransMolecular, Inc. TOTAL GRANT: $17,000 PROJECT PERIOD: 3/07-12/07 PROJECT: Kininogen in ocular angiogenesis-mediated disorders SPONSOR: Vascular Vision Pharmaceuticals Co. TOTAL GRANT: $100,000 PROJECT PERIOD: 10/05-3/07 PROJECT: Wound healing and haemostatic treatment using novel phar-
maceutical nanoploymer or nanoparticles formulation of thyroid hormone T4 analogs SPONSOR: Charitable Leadership Foundation Medical Technology Acceleration Program TOTAL GRANT: $306,900 PROJECT PERIOD: 4/06-4/07 PROJECT: Tissue factor/VIIa modulation in ocular angiogenesis SPONSOR: Vascular Vision Pharmaceuticals Co./NIH (Eye Institute and Cancer Institute) TOTAL GRANT: $100,000 PROJECT PERIOD: 10/05-until completion
ACPPresRepFINAL
4/4/08
3:58 PM
Page 31
P 31
PROJECT: PK and PD evaluations of Othera’s lead compounds in a murine model of Endotoxin-induced Cytokine release SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $54,060 PROJECT PERIOD: 2/07-7/07
PROJECT: Cellular and molecular mechanisms of TPH in the modulation of complement activation and inflammation (amendment) SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $48,000 PROJECT PERIOD: 3/06-7/07
PROJECT: Evaluation of Othera’s lead compounds in a murine model of Oxazolone-induced ear edema SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $13,440 PROJECT PERIOD: 2/07-7/07
PROJECT: Neuronal protective effects and mechanisms of Othera’s OT551 nanoparticles SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $56,000 PROJECT PERIOD: 9/06-7/07
PROJECT: Anti-cancer efficacy of Othera’s OT series
PROJECT: Analog screening program
SPONSOR: Othera Pharmaceuticals, Inc.
SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $693,000 PROJECT PERIOD: 9/06-12/07 PROJECT: Retinal neovascularization in infant mice in ROP SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $14,400 PROJECT PERIOD: 11/06-12/07 PROJECT: The effect of OT551 on nuclear factor-kB pathway activation SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $91,800 PROJECT PERIOD: 12/06-12/07 PROJECT: Funding for Postdoctoral fellow SPONSOR: Othera Pharmaceuticals, Inc TOTAL GRANT: $43,802 PROJECT PERIOD: 1/07-12/07 PROJECT: Reversal of chemotherapy resistance with Othera analogs SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $81,600
SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $76,250 PROJECT PERIOD: 12/06-12/07 PROJECT: Cancer and drug associated thrombosis TOTAL GRANT: $78,900 PROJECT PERIOD: 1/07-12/07 PROJECT: OT551 and OT304 nanoparticle formulation: Synthesis and characterization. SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $66,000 PROJECT PERIOD: 6/07-until complete PROJECT: Enhancing the efficacy of chemotherapeutic breast cancer treatment with non-anticoagulant heparin SPONSOR: U.S. Dept. of Defense Breast Cancer Research Program TOTAL GRANT: $377,620 PROJECT PERIOD: 4/07-3/09 PROJECT: Role of Pentasaccharide Fondaparinux versus low molecular weight Heparin in wound healing (Amended to study role in cancerassociated thrombosis) SPONSOR: Sanofi-Aventis and GlaxoSmithKline TOTAL GRANT: $35,700 PROJECT PERIOD: 11/05-until complete PROJECT: Role of Heparin and Heparin derivatives beyond anticoagula-
PROJECT PERIOD: 12/06-12/07
tion
PROJECT: Assay of tetrac in plasma samples
SPONSOR: Sanofi-Aventis
SPONSOR: Charitable Leadership Foundation Medical Technology
Acceleration Program TOTAL GRANT: $30,000 PROJECT PERIOD: 12/06-11/07
PROJECT: PK and PD of oral Heparin SPONSOR: Emisphere Technologies, Inc. TOTAL GRANT: $182,275 PROJECT PERIOD: 10/05-12/06 PROJECT: Tetrac stability study SPONSOR: Charitable Leadership Foundation Medical Technology Acceleration Program TOTAL GRANT: $10,260 PROJECT PERIOD: 11/06-3/07 PROJECT: In vitro evaluation of platelet activation by the test article in human blood SPONSOR: Merck and Co., Inc. TOTAL GRANT: $23,750 PROJECT PERIOD: 2/07-2/08 PROJECT: Anti-angiogenesis and anti-cancer efficacies and mechanisms of TM601 SPONSOR: Transmolecular, Inc. TOTAL GRANT: $66,600 PROJECT PERIOD: 2/07-8/07 PROJECT: PK/PD of OT304 and OT551 in rat Carrageenan-induced paw edema model SPONSOR: Othera Pharmaceuticals, Inc TOTAL GRANT: $10,080 PROJECT PERIOD: 2/07-7/07
TOTAL GRANT: $100,000 PROJECT PERIOD: 6/06-5/07
Albany College of Pharmacy PRESIDENT’S REPORT 2007
PROJECT: Cellular and molecular mechanisms of TPH in the modulation of complement activation and inflammation SPONSOR: Othera Pharmaceuticals, Inc. TOTAL GRANT: $54,000 PROJECT PERIOD: 3/06-7/07
ACPPresRepFINAL
4/4/08
3:58 PM
Page 32
Pharmacy Practice P U B L I C AT I O N S George R. Bailie Bailie GR, Elder SJ, Mason NA, et al. Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: Results from the Dialysis Outcomes and Practice Patterns Study. Nephrology Dialysis Transplantation 22:1163-1170, February 2007. Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, et. al. Diuretic use, residual renal function and mortality among hemodialysis patients in DOPPS. American Journal of Kidney Disease 49:426-431, 2007. Michael R. Brodeur Beizer JL, Brandt NJ, Brodeur MR, Jeffery SM, Plein JB, Stratton MA, Bouwmeester C and D’Antonio PM. Geriatric Pharmacy Curriculum Guide, 2nd Edition, Alexandria, Va.: American Society of Consultant Pharmacists, 2007. Susan P. Bruce Bruce SP, Bower A, Hak E and Schwartz AH. Utilization of the Center for the Advancement of Pharmaceutical Education Educational Outcomes, Revised Version 2004: Report of the 2005 American College of Clinical Pharmacy Educational Affairs Committee. Pharmacotherapy 26(8):1193200, August 2006. Bruce SP, Bower A, Hak E and Schwartz AH. Utilization of the Center for the Advancement of Pharmaceutical Education Educational Outcomes, Revised Version 2004: Report of the 2005 American College of Clinical Pharmacy Educational Affairs Committee. American Journal of Pharmaceutical Education 70(4):79, 2006.
Thomas P. Lodise Lodise TP, Lomaestro BM and Drusano GL. Application of antimicrobial pharmacodynamic concepts into clinical practice: Focus on betalactam antibiotics: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 26 (9):1320-32, September 2006.
Bruce SP. Febuxostat: A selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout. The Annals of Pharmacotherapy 40(12):2187-94, November 2006.
Laplante KL, Rybak MJ, Tsuji B, Lodise TP and Kaatz GW. Fluoroquinolone resistance in Streptococcus pneumoniae: Area under the concentration-time curve/MIC ratio and resistance development with Gatifloxacin, Gemifloxacin, Levofloxacin and Moxifloxacin. Antimicrobial Agents and Chemotherapy 51(4):1315-20, April 2007.
Leon E. Cosler Kuderer NM, Dale DC, Crawford J, Cosler LE and Lyman GH. Mortality, morbidity and cost associated with febrile neutropenia in adult cancer patients. Cancer 106(10):2258-66, 2006. Angela C. Dominelli Dominelli A, Iwanowicz SL, Bailie GR, Clarke DW and McGraw PS. A project management approach to an ACPE accreditation self-study. American Journal of Pharmaceutical Education 71(2):Article 23, 2007. Darren W. Grabe Grabe DW. Update on clinical practice recommendations and new therapeutic modalities for treating anemia in patients with chronic kidney disease. American Journal of Health-System Pharmacy 64:8-14,2007. Macary Weck Marciniak Iwanowicz SL, Marciniak MW and Zeolla MM. Obtaining and providing health information in the community pharmacy setting. American Journal of Pharmaceutical Education 70(3):57, 2006. Marciniak MW. OTC product: PediaCare long-acting cough freezer pops. Journal of the American Pharmacists Association 46(4):e50, July-August 2006.
Lodise TP,Miller CD,Graves J,Furuno JP,McGregor JC,Lomaestro BM, Graffunder E and McNutt LA. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multi-drug resistance. Antimicrobial Agents and Chemotherapy 51(2):417-22,February 2007. Lodise TP, Lomaestro BM and Drusano GL. Piperacillin/Tazobactam for Pseudomonas aeruginosa infections: Clinical implications of an extended infusion dosing strategy. Clinical Infectious Diseases 44(3):357-63, February 2007. Sommo P, Lodise TP and Lomaestro BM. Use of Meropenem in patients with a history of Pencillin allergy. New York State Journal of Health-System Pharmacy 25(5):20-22, 2006. John M. Polimeni Holguin-Veras J, Perez N, Cruz B and Polimeni JM. Effectiveness of financial incentives for off-peak deliveries to restaurants in Manhattan, New York. Transportation Research Record 1966:51-59, 2006. Polimeni JM and Polimeni RI.Jevons’Paradox and the myth of technological liberation.Ecological Complexity 3(4):344-353,2006.
Dominelli A, Marciniak MB and Jarvis J. Service preference differences between community pharmacy patrons and supermarket pharmacy patrons. Health Marketing Quarterly 23(1):57-79, 2005.
Polimeni JM and Polimeni RI. Simulating the effects of public-policy on residential development in the Hudson River Valley. Journal of Business and Economics Research 5(1):41-58, 2007.
Marciniak MW. A day in the life of an APhA media advisor. Student Pharmacist 2(1):15, September/October 2006.
Polimeni JM, Polimeni RI and Trees WS. Extending the augmented Solow Growth Model to explain transitional economies. Romanian Journal of Economic Forecasting 1, 2007.
Gina D. Garrison Garrison GD. Cautious use of nonprescription therapies in patients with cardiovascular disease. APhA Student Pharmacist, July/August 2007.
Polimeni JM. Psychentropy: An alternative model of human welfare. International Journal of Transdisciplinary Research 2(1):93-112, 2007. Polimeni RI, Polimeni JM and Onyeiwu S. Labor migration and ruralsuburban symbiosis in Igbo society. International Business and Economics Research Journal 6(6): 1-14, 2007. Holguin-Veras J, Silas M, Polimeni JM and Cruz B. An investigation on the effectiveness of joint receiver-carrier policies to increase truck traffic in the off-peak hours/Part I:The Behavior of Receivers. Networks and Spatial Economics 7(3):277-295, 2007. Sarah L. Scarpace Pasquale D, Ramanathan N, Scarpace SL, Hung N, Jackson AI and Ramanarayanan J. Individualized dosing of Fludarabine for low grade lymphoproliferative disorders: Results in administration of less medication with fewer infections and equivalent survival. Blood 108(11s2):332b, 2006. Ramanarayanan J and Scarpace SL. Acute drug-induced hepatitis due to erlotinib. Journal of the Pancreas 8(1):39-43, January 2007.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 33
P 33
Thomas P. Lodise PROJECT: Impact of Vancomycin MIC on outcomes of patients with MRSA bacteremia SPONSOR: Cubist Pharmaceuticals CO-INVESTIGATORS: Graffunder E, Evans A, Lomaestro B and Stellrecht KA TOTAL GRANT: $50,000 PROJECT PERIOD: 12/06-6/07 A B ST R A C T S / P R E S E N TAT I O N S Laurie L. Briceland Briceland LL, Brodeur MR, Bruce SP and Zeolla MM. Approaches to curricular revision: Sharing ideas on how to meet ACPE standards. Annual Meeting of the American Association of Colleges of Pharmacy, San Diego, Calif., July 2006. Michael R. Brodeur Brodeur MR. Opioids: A drug class review. Colonie Emergency Medical Services, Albany, N.Y. November 2006. Brodeur MR. Antiemetics. Albany Medical Center 3rd Annual Winter Emergency Medical Services Symposium, Jiminy Peak, Mass., January 2007. Brodeur MR and Parker KF. Grand rounds: Clinical complex patients. American Society of Consultant Pharmacists Midyear Conference, Hollywood, Fla., May 2007. Brodeur MR and Saffel D. Proton pump inhibitors: PointCounterpoint. American Society of Consultant Pharmacists Midyear Conference. Hollywood, Fla., May 2007 Susan P. Bruce Bruce SP. Update on curricular ACPE standards and guidelines. Annual Meeting of the American Association of Colleges of Pharmacy, San Diego, Calif., July 2006. Bruce SP. Involving APPE students in didactic and experiential teaching activities. Annual Meeting of the American Association of Colleges of Pharmacy, San Diego, Calif., July 2006. Jennifer Cerulli Cerulli J. Developing and sustaining community pharmacy practice experiences. American Association of Colleges of Pharmacy Institute: Building an Effective Structure and Process for Experiential Education, Landsdowne, Va., November 2006. Leon E. Cosler Ferro SA, Cosler LE, Myer BS, Scarpace SL, Culakova E,Wolff DA, Poniewierski MS and Lyman GH. Are phenothiazines overused in cancer chemotherapy? Annual Meeting of the American College of Clinical Pharmacy, St. Louis, Mo., October 2006. Cosler LE. An economic analysis of a 21-gene RT-PCR assay for predicting breast cancer recurrence and response to adjuvant treatment. Pharmacist Advisory Board - Genomic Health, Inc., Redwood City, Calif., September 2006. Ferro S, Myer BS,Cosler LE, Scarpace SL, Culakova E, Wolff DA, Poniewierski MS and Lyman GH. Are phenothiazines overused in cancer chemotherapy? American College of Clinical Pharmacy Annual Meeting. St. Louis, Mo., October 2006. Angela C. Dominelli Dominelli AC. Medicare Part D: After the dust settles. Association of State Medicaid Pharmacy Directors, Milwaukee, Wisc., July 2006. Dominelli AC, Clarke DW, Reed T, Flint RW, Papandrea D and Khan S. The impact of pharmaceutical education on attitudes and knowledge of direct-to-consumer advertising. Annual Meeting of the Society for Medical Decision Making, Boston, Mass., October 2006. Dominelli AC. Guess what: Your drug is not covered. Health Policy Consortium of the Greater Capital District, Schenectady, N.Y., October 2006. Dominelli AC. An update of the Medicare Part D Program. Senior Law Day, Albany Law School, Albany, N.Y., October 2006. Dominelli AC. Tools for success: Helpful strategies for new and experienced Practitioners. American College of Clincial Pharmacy Spring Practice and Research Forum, Memphis, Tenn., April 2007. Dominelli A. Medicare Part B: Implications for ERSD patients.Albany Medical Center Dialysis and Transplant Unit, Albany, N.Y., June 2007.
Sara E. Dugan Dugan SE. Drug interactions with the MS patient. National Multiple Sclerosis Society, Albany, N.Y., October 2006. Dugan SE. Health screenings for people with developmental disabilities. Cerebral Palsy Association of New York State, Albany, N.Y., October 2006. Dugan SE. Current medications for behavioral disorders in special education. New York State United Teachers conference, Albany, N.Y., October 2006. Dugan SE and Rosenfeld WE. Aging with a developmental disability: Medical and psychiatric considerations. American Society of Consultant Pharmacists Annual Meeting, Phoenix, Ariz., November 2006. Dugan SE. Aging with a developmental disability: Psychiatric considerations. College of Psychiatric and Neurologic Pharmacists Annual Meeting, Colorado Springs, Co., April 2007. Dugan SE. Managing behavioral disorders and epilepsy in the MRDD population. Program for MRDD healthcare providers, program administrators and direct care staff sponsored by Abbott Laboratories, Latham, N.Y., May 2007. Dugan SE. Managing behavioral disorders and epilepsy in the MRDD population. Program for MRDD healthcare providers, program administrators and direct care staff sponsored by Abbott Laboratories, Fishkill, N.Y., May 2007. Dugan SE. Ask the pharmacist. Multiple Sclerosis Society Support Group, Albany, N.Y., May 2007. Andrew Flynn Flynn A and Vadala T. Pharmacy Board Review. Student Pharmacists Society of the State of New York, Albany, N.Y., January 2007. Darren W. Grabe Grabe DW. Existing and evolving strategies for managing anemia in CKD. 41st American Society of Health-system Pharmacists Midyear Clinical Meeting, Anaheim, Calif., December 2006. Grabe DW. New directions in the management of anemia of Chronic Kidney Disease. Medscape CME Spotlight, Anaheim, Calif., December 2006. Grabe DW, Manley HM and Barton Pai A. Therapeutic advances in Chronic Kidney Disease: Management of anemia. Medscape Nephrology Cybersession, June 2007. Grabe DW, St. Peter W and Brophy D. The pharmacist’s role in collaborative care: Focus on the management of anemia for patients with Chronic Kidney Disease. American Society of Health-system Pharmacists Summer Meeting, San Francisco, Calif., June 2007. Nicole M. Stack Lodise Stack NM. Treating tobacco dependence in the obstetric population. Women, Children and Mental Health: Current Challenges in Clinical Practice, Albany Medical Center, Albany, N.Y., October 2006. Stack NM. Emergency contraception: The pharmacist’s role. Pharmacy in the News Continuing Education program, Albany College of Pharmacy, November 2006. Stack NM, Patel N and Dugan SE. Impact of extra-curricular focusspecific coursework on student pharmacist’s attitudes towards patient care services and the growing need to be incorporated intracurricularly. American Association of Colleges of Pharmacy Annual Meeting, Orlando, Fla., July 2007. Stack NM. A Look at Plan B from the pharmacist’s perspective. Provider and Counselor Education Program. Family Planning Advocates of New York State Annual Conference, Albany, N.Y., March 2007. Stack NM. Treating tobacco dependence at Albany Medical Center. Alcoholism and Substance Abuse Providers of NYS Addiction Institute 2007, Saratoga, N.Y., March 2007. Stack NM. Update on tobacco cessation use and dependence. Albany College of Pharmacy Pharmacy Practice Institute, Albany, N.Y., March 2007. Stack NM. Tobacco dependence: Why is it so difficult to quit? Northeastern Chapter of the New York State Council of HealthSystem Pharmacists, Albany, N.Y., February 2007.
Albany College of Pharmacy PRESIDENT’S REPORT 2007
GRANTS
ACPPresRepFINAL
4/4/08
3:58 PM
Page 34
Thomas P. Lodise Lodise TP, Lomaestro BM and Drusano GL. Comparison of probability of target attainment for Meropenem between one-compartment vs. two-compartment Monte Carlo Simulation models. 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, Canada, October 2006. Lodise TP, Nau R, Ambrose PG, Jones RN, Drusano GL and Sörgel F. Comparison of the probability of target attainment between Ceftazidime and Meropenem in cerebrospinal fluid and plasma against nosocomial gram-negative bacilli (Abstract #1704). 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, Canada, October 2006. Lodise TP and McKinnon PS. A clinical prediction tool to identify risk for adverse outcomes in patients with Staphylococcus aureus bacteremia. 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, Canada, October 2006. Miller CD and Lodise TP. A prediction model to identify patients with Pseudomonas aeruginosa respiratory tract infections at risk for multiple drug resistant P. aeruginosa. 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, Canada, October 2006. Lodise TP. Comparison of the probability of target attainment between Ceftriaxone and Cefepime in the cerebrospinal fluid and plasma against Streptococcus pneumoniae. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, Calif., September 2006. Lodise TP. Pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, Calif., September 2006. Mohr JF, Peymann PJ, Troxell E, Lodise TP and Ostrosky-Zeichner L. Risk factors associated with hyperglycemia in patients receiving Gatifloxacin and Levofloxacin. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, Calif., September 2006. Lodise TP. Community-acquired MRSA: An alert to clinicians. American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim, Calif., December 2006. Lodise TP. Gram-negative resistance and PK/ PD considerations: A Focus on β-lactam antibiotics. San Bernadino Medical Center Third Annual Infectious Diseases Seminar, San Bernadino, Calif., November 2006. Lodise TP. Management of MRSA: Has the treatment paradigm changed? New York State Chapter of the American College of Clinical Pharmacy Fall Clinical Meeting, Albany, N.Y, October 2006. Lodise TP.Treatment of Staphylococcus aureus in the era of antibiotic resistance. New York State Council of Health-system Pharmacists MidYear Clinical Meeting. Niagara,N.Y.,October 2006. Lodise TP. Basic statistics for the clinician. Albany Medical Center Neonatal Department, Albany, N.Y., February 2007. Lodise TP. Inferential statistics for the clinician. Albany Medical Center Neonatal Department, Albany, N.Y., March 2007. Lodise TP. Treatment of Staphylococcus aureus in the era of antibiotic resistance. Champlain Valley Physicians Hospital Medical Grand Rounds, Plattsburgh, N.Y., March 2007. Lodise TP. Clinical application of PK/PD principles: A focus on antibiotics. St. Elizabeth Medical Center Pharmacology Teaching Day, Utica, N.Y., March 2007. Lodise TP. Community-acquired Methicillin resistant Staphylococcus aureus: An emerging public health threat. Continuing Education program, Albany College of Pharmacy, Albany, N.Y., February 2007. Margaret M. Malone Alger-Mayer S, Malone M and Polimeni JM. Long term nutritional supplement intake after gastric bypass surgery. NAASO: The Obesity Society Annual Scientific Meeting, Boston, Mass., October 2006. Alger-Mayer S, Malone M and Polimeni JM. Long term changes in Gormally Binge Eating and Beck Depression Inventory Scores after gastric bypass surgery. NAASO:The Obesity Society Annual Scientific Meeting, Boston, Mass., October 2006. Alger-Mayer S, Malone M and Polimeni JM. Correlation between required pre-operative weight loss prior to gastric bypass surgery and three-year weight loss outcome. NAASO: The Obesity Society Annual Scientific Meeting, Boston, Mass., October 2006. Alger-Mayer S, Clark S., Malone M and Polimeni JM. Vitamin D and PTH assessment in patients 3 years after gastric bypass. NAASO: The Obesity Society Annual Scientific Meeting, Boston, Mass., October 2006.
Macary Weck Marciniak Marciniak MW. Facilitator for Phi Delta Chi Fraternity Eleventh Leader-Development Seminar, Ann Arbor, Mich., August 2006. Marciniak MW. Introducing student pharmacists to media training concepts during an immunizations and emergency preparedness course. 9th Nonprescription Medicines Academy Conference, Cincinnati, Ohio, October 2006. Marciniak MW. Building Media Relations Workshop. American Pharmacists Association Academy of Student Pharmacists Midyear Regional Meeting, Chicago, Ill., October 2006. Marciniak MW. Building Media Relations Workshop. American Pharmacists Association Academy of Student Pharmacists Midyear Regional Meeting, Richmond, Va., November 2006. Marciniak MW. A new practitioner’s survival toolkit. Pharmacists Society of the State of New York Midwinter Conference, Albany N.Y., January 2007. Marciniak MW. Nutritional supplements: What’s the evidence? Iowa Pharmacy Association Educational Expo, Des Moines, Iowa, January 2007. Marciniak MW. OTC use in pediatric patients. Iowa Pharmacy Association Educational Expo, Des Moines, Iowa, January 2007. Marciniak MW and Esker S. Heart Disease. Schenectady Today Show: Wednesday Edition (live interview), February 2007. Marciniak MW. Choosing the right OTC pain reliever. Capital News 9 (taped interview), March 2007. Marciniak MW and Kumbera P.The ABCs of conducting and documenting a medication therapy review, American Pharmacists Association Annual Meeting, Atlanta, Ga., March 2007. Marciniak MW and Williams EM. Smooth transitions: What to expect as a new practitioner. Albany College of Pharmacy, Albany N.Y., May 2007. Christopher D. Miller Miller CD and Lodise T. Clinical prediction tool to identify patients with Pseudomoas aeruginosa respiratory tract infections at greatest risk for multi-drug resistance. Infectious Diseases Society of America Annual Meeting. Toronto, Canada, October 2006. Faragon J, Miller C, El-Kholi R, Lodise T. and Fish D. Evaluation of a standardized antiretroviral therapy order form intended to decrease prescribing errors. Infectious Diseases Society of America Annual Meeting Annual Meeting. Toronto, Canada, October 2006. Miller C. and Faragon J. NNRTI- versus PI-based antiretroviral therapy: A flip of the coin. New York State Chapter of the American College of Clinical Pharmacy Fall Clinical Meeting, Albany, N.Y., October 2006. Miller C. Medication errors with antiretroviral therapy: Getting it right. New York State Department of Corrections Pharmacy Telemedicine Conference, Albany Medical Center, Albany, N.Y., January 2007. Miller C. Antiretroviral update: Keeping up with the changing landscape. Capital Area Pharmacist’s Society Meeting, Albany, N.Y., February 2007. Miller C. Opportunistic infection prophylaxis: A focus on medication management. Internal Medicine Residency Conference, St. Clare’s Hospital, Schenectady, N.Y., February 2007. Miller C. Antiretroviral therapy update:Keeping Up. ACP Pharmacy Practice Institute Annual Meeting,Albany,N.Y.,March 2007. Miller C. Approach to the antiretroviral naïve patient. New York State Correctional Pharmacist’s Annual HIV Update, Utica, N.Y., April 2007. Miller C. Toxicities and drug interactions with antiretroviral therapy. Albany Medical Center Resident Conference. Albany, N.Y., May 2007.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 35
P 35
Polimeni JM, Polimeni RI, Shirey RL and Trees WS. Protecting the U.S. food supply from a terrorist attack. New York State Economics Association, Loudonville, N.Y., September 2006. Polimeni JM, Alger SM, Clark S and Malone M. Vitamin D and PTH assessment in patients three years after gastric bypass. NAASO 2006 Annual Scientific Meeting, Boston, Mass., October 2006. Polimeni JM, Polimeni RI and Tripon A. Agritourism and community supported agriculture: Examples relevant to Romania. Applied Research for Sustainable Development in Romania, Targu-Mures, Romania, November 2006. Polimeni JM, Polimeni RI and Pociovalisteanu D. Structural adjustment and the resilience of traditional institutions. Economics and Globalization Conference, Targu-Jiu, Romania, November 2006. Polimeni JM and Polimeni RI. Structural adjustment and labor migration in Igbo society. Eastern Economics Association, New York, N.Y., February 2007. Polimeni JM. The role of women cross-border traders in increasing capital flows in West Africa. Eastern Economics Association, New York, N.Y., February 2007. Polimeni JM. Jevons’ Paradox and the economic implications for Europe. European and Applied Business Research, Padua, Italy, June 2007. Polimeni JM. Assessment of the economics curriculum at a college of pharmacy. College Teaching and Learning Conference, Padua, Italy, June 2007. Polimeni JM and Polimeni RI. Labor migration and rural-suburban symbiosis in Igbo society. 2007 International Applied Business Research Conference, Mazatlan, Mexico, March 2007. Polimeni JM. Jevons’ Paradox and the implications for Europe. 9th International Association of Energy Economists Conference European Energy Conference, Florence, Italy, June 2007. Sarah L. Scarpace Scarpace SL. Utility of a website to improve the clerkship experience and enhance clinical team collaboration. American Association of Colleges of Pharmacy Annual Meeting, San Diego, Calif., July 2006. Scarpace SL. Antiemetics: ASCO vs. NCCN 2006 guidelines. Stratton VAMC Cancer Team, Albany, N.Y. July 2006. Scarpace SL. CAM as chemoprevention: What is the evidence? Roswell Park Cancer Institute Oncology Pharmacy Symposium, Buffalo, N.Y., November 2006. Scarpace SL. Cancer screening and the community pharmacist: How you can raise awareness for screening and prevention. Capital Area Pharmacists’ Society meeting, Latham, N.Y. January 2007. Scarpace SL. Not so InSERMountable: Breast cancer chemoprevention. Continuing Education program, Albany College of Pharmacy, Albany, N.Y., January 2007. Scarpace SL. Breast cancer: Treatments and side effects. Gilda’s Club, Latham, N.Y., January 2007. Scarpace SL, Ramanathan N, Ramanarayanan J, Jackson AI and Pasquale D. Administration of greater than two cycles of fludarabine increases the risk of infection independent of other risk factors. American College of Clinical Pharmacy Spring Practice and Research Forum, Memphis, Tenn., April 2007. Scarpace SL. Drug therapy update: Renal cell carcinoma. Continuing Education program, New York State Council of Health-system Pharmacists, Albany, N.Y. April 2007. Scarpace SL. Cancer screening and the community pharmacist: How you can help raise awareness for screening and prevention. Continuing Education program, Northern New York Pharmacists’ Society, Potsdam, N.Y., April 2007. Scarpace SL. Target practice: A review of the arrows in our cancer care armamentarium. Western New York Society of Health System Pharmacists Meeting, Buffalo, N.Y., May 2007. Murdico A and Scarpace SL. Does following the NCCN practice guideline for anemia improve chemotherapy dose-intensity? 3rd Annual Hematology/Oncology Pharmacy Association Meeting, Denver, Co., June 2007. Scarpace SL and Cosler L. Monoclonal antibodies: Extending life and the budget. Medicaid DUR Conference, Albany, N.Y., June 2007. Scarpace SL. Significant Papers in Hematology/Oncology: Head and Neck Cancers. 3rd annual national Hematology Oncology Pharmacy Association meeting, Denver, Co, June, 2007.
Kara L. Shirley Shirley KL, Gupta R and Nelson B. Cardiovascular monitoring of atypical antipsychotic pharmacotherapy in schizophrenia and bipolar spectrum disorders. College of Psychiatric and Neurologic Pharmacists 10th Annual Meeting, Colorado Springs, Colo., April 2007. Malik A and Shirley KL. Cognition and pharmacotherapy in adult ADHD. American Psychiatric Association Annual Meeting, San Diego, Calif., May 2007. Shirley KL. Pharmacotherapy of treatment-refractory depression. Psychiatric Medical Management, Albany College of Pharmacy, Albany N.Y., January 2007. Mario M. Zeolla * Zeolla MM and Cerulli J. Evaluating dietary supplement information resources currently used by practicing pharmacists. American Association of Colleges of Pharmacy Annual Meeting, San Diego, Calif., July 2006. Zeolla MM. Update on clinical trials of dietary supplements: The good, the bad and the unexpected. Continuing Education program, Albany College of Pharmacy, Albany, N.Y., May 2007. Zeolla MM. Strategies for success as a new practitioner. Continuing Education program, American College of Clinical Pharmacy Spring Practice and Research Forum, Memphis, Tenn., April 2007.
Albany College of Pharmacy PRESIDENT’S REPORT 2007
John M. Polimeni Polimeni JM and Polimeni RI. A multi-scale integrated assessment of energy sector in Romania. 5th Biennial International Workshop: Advances in Energy Studies Perspectives on Energy Future, Porto Venere, Italy, September 2006.
ACPPresRepFINAL
4/4/08
3:58 PM
Page 36
Pharmaceutical Sciences P U B L I C AT I O N S Prashant J. Chikhale Killian DM, Hermeling S and Chikhale PJ. Targeting the cerebrovascular large neutral amino acid transporter (LAT1) isoform using a novel disulfide-based brain drug delivery system. Drug Delivery 14:25-31, 2007. Carlos Feleder Feleder C and Blatteis CM. The role of the spleen in the febrile response. Journal of Thermal Biology 31:220-228, 2006. Li Z, Perlik V, Feleder C, Tang Y and Blatteis CM. Kupffer cell-generated PGE2 triggers the febrile response of guinea pigs to intravenously injected LPS. American Journal of Physiology 290:R1262-1270, 2006. Feleder C, Perlik V and Blatteis CM. Preoptic nitric oxide attenuates endotoxic fever in guinea pigs by inhibiting the POA release of norepinephrine. American Journal of Physiology, June 20, 2007 (Epub ahead of print). Feleder C, Perlik V and Blatteis CM. Preoptic norepinephrine mediates the febrile response of guinea pigs to lipopolysaccharide. American Journal of Physiology, June 20, 2007, (Epub ahead of print). Robert M. Levin Mannikarottu A., Lin AD, Whitebeck C, Leggett R, Kogan B and Levin R. Effect of partial bladder outlet obstruction on nitrotyrosine levels and their correlation with contractile function. Neurourology and Urodynamics 25:397-401, 2006. Lin AD-Y, Levin R, Kogan B, Whitbeck C, Chichester P, Sokol R and Mannikarottu A. Estrogen induced functional hypertrophy and increased force generation of the female rabbit bladder. Neurourology and Urodynamics 25:473-479, 2006. Lin AD-Y, Mannikarottu AS, Kogan BA, Chichester P, Leggett RE and Levin RM. Estrogen induces angiogenesis of the female rabbit bladder. Journal of Endocrinology 190:241-246, August 2006. Levin RM, Whitbeck C, Sourial MW, Tadrous M and Millington WR. Effects of dextromethorphan on in vitro contractile responses of mouse and rat urinary bladders. Neurourology and Urodynamics 25: 802-807, 2006. Lin AD, Levin R, Kogan BA, Whitbeck C, Leggett RE, Kearns C and Mannikarottu A. Alteration of contractile and regulatory proteins in estrogen-induced hypertrophy of female rabbit bladder. Urology 68:1139-1143, 2006. Palmieri K, Mannikarottu A, Chicester P, Kogan B, Leggett RE, Whitbeck C and Levin RM. The effects of cyclical estrogen on bladder and urethral structure and function. British Journal of Urology 99:171176, 2007. Whitbeck C, Chichester P, Sokol R and Levin RM. Role of nitric oxide in urinary bladder function: Effect of L-Arginine in the presence and absence of partial outlet obstructions. Urologi Internationalis 78:3036, 2007. Arecht MM, Chichester P, Michel MC and Levin RM. Effect of short-term outlet obstruction on rat bladder nerve density and contractility. Autonomic and Autacoid Pharmacology 27:47-53, 2007. Lin AD, Mannikarottu A, Kogan BA, Whitbeck C, Leggett RE and Levin RM. Effect of bilateral in vivo ischemia/reperfusion on the activities of superoxide dismutase and catalase: Response to a standardized grape suspension. Molecular and Cellular Biochemistry 296:11-16, 2007. Agartan CA, Leggett RE, Kogan BA and Levin RM. Effect of age on the response to in-vitro ischemia of the rabbit bladder. Urologi Internationalis 78:155-159, 2007. Linn A D-Y, Levin RM, Kogan BA, Whitbeck C, Leggett RE and Mannikarottu AS. Alteration of contractile and regulatory proteins in estrogen-induced hypertrophy of female rabbit bladder. Urology 68(5):1139-43, November 2006. Onal B, Levin RM, Kogan BA, Guven A, Leggett RE and Mannikarottu AS. Novel alterations in superoxide dismutase and catalase activities in the female rabbit bladder subjected to hormonal manipulations. International Urology and Nephrology, February 28, 2007 (Epub ahead of print). Juan Y-S, Onal B, Broadaway S, Cosgrove J, Leggett RE,Whitbeck C, Sokol R and Levin RM. Effect of castration on male rabbit lower urinary tract tissue enzymes. Molecular and Cellular Biochemistry 301(1-2):227-33, 2007 (Epub February 9, 2007). Guven A, Onal B, Kalorin C, Whitbeck C, Chichester P, Kogan BA, Levin RM and Mannikarottu AS. Long term partial bladder outlet obstruction induced contractile dysfunction in male rabbits: A role for rhokinase. Neurourology and Urodynamics, May 4, 2007 (Epub ahead of print). Guven A, Kalorin C, Onal B,Whitbeck C, Chichester P, Kogan BA, Levin RM and Mannikarottu AS. Novel biomarkers of bladder decompensation after partial bladder obstruction. Neurourology and Urodynamics, May 8, 2007, (Epub ahead of print).
William R. Millington Gรถktalay G, Cavun S, Levendusky MC, Hamilton JR and Millington WR. Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal. European Journal of Pharmacology 530:95-102, 2006. Gรถktalay G, Cavun S, Levendusky MC, Resch GE,Veno PA and Millington WR. Hemorrhage activates proopiomelanocortin neurons in the rat hypothalamus. Brain Research 1070:45-55, 2006. Levin RM, Whitbeck C, Sourial MW, Tadrous M and Millington WR. Effects of dextromethorphan on the in vitro contractile responses of mouse and rat urinary bladder. Neurourology and Urodynamics 25:802-807, 2006. Adwoa O. Nornoo Nornoo AO and Elwell RJ. Stability of Vancomycin in icodextrin peritoneal dialysis solution. Annals of Pharmacotherapy 40(11):1950-4, November 2006. Nornoo AO, Owusu-Obeng A, Myer BS, Nguyen H and Reed R. Effect of oral microemulsions on the permeability of paclitaxel across rat GIT and caco-2 cell monolayers. American Association for Cancer Research Annual Meeting Proceedings; April 14-18, Los Angeles, Calif. Philadelphia, Pa.: AACR, 2007. Gail Goodman Snitkoff Snitkoff GG and Snitkoff LS. Use of enriched case studies to enhance empathy in pharmacy students. Journal of Pharmacy Teaching 13(2):516, 2006. Snitkoff GG. Immunology in Comprehensive Pharmacy Review, 6th Edition (L. Shargel, ed.), Philadelphia, Pa.: Lippincott, Williams and Wilkins, 2006. Snitkoff GG. Microbiology in Comprehensive Pharmacy Review, 6th Edition (L. Shargel, ed.), Philadelphia, Pa.: Lippincott, Williams and Wilkins, 2006. Snitkoff GG. Review of The Power of Plagues in Focus on Microbiology Education 12(4):7, Summer 2006. HaiAn Zheng Zheng H, Zhao J, Sheng WY, Xie X-Q. A transmembrane helix-bundle from G-protein coupled receptor CB2: Biosynthesis, purification, and NMR characterization, Biopolymers 83(1):46-61, 2006 Zhao J, Zheng H and Xie X-Q. NMR characterization of recombinant transmembrane protein CB2 Fragment CB2 (180-233). Protein and Peptide Letters 13(4):335-42, 2006.
GRANTS Prashant J. Chikhale PROJECT: Acharan sulfate:A potential brain tumor therapeutic agent SPONSOR: Albany College of Pharmacy Intramural Grant TOTAL GRANT: $4,500 PROJECT PERIOD: 2007-2008 Richard E. Dearborn Jr. PROJECT: Elucidation of vitamin D3 up-regulated protein 1 (VDUP1) tumor suppressor function during brain development in Drosophila SPONSOR: Albany College of Pharmacy Intramural Grant TOTAL GRANT: $4,000 PROJECT PERIOD: 2006-2007 PROJECT: Mutagenic analysis of conserved amino acid function in the tumor suppressor vitamin D3 up-regulated protein 1 (VDUP1) SPONSOR: Albany College of Pharmacy Intramural Grant TOTAL GRANT: $5,000 PROJECT PERIOD: 2007-2008
Carlos Feleder PROJECT: Splenic regulation of endotoxic fever SPONSOR: Albany College of Pharmacy Intramural Grant TOTAL GRANT: $5,000 PROJECT PERIOD: 2006-2007 PROJECT: The systemic inflammatory response to pathogens in the brain SPONSOR: Albany College of Pharmacy Intramural Grant CO-INVESTIGATOR: William R. Millington TOTAL GRANT: $4,920 PROJECT PERIOD: 2007-2008
ACPPresRepFINAL
4/4/08
3:58 PM
Page 37
P 37
Richard E. Dearborn Jr. Dearborn Jr. RE, Snyder RG, Levendusky MC and Voigt JM. Sustained expression of the vitamin D3 up-regulated protein 1 (VDUP1) tumor suppressor correlates with glial subtype differentiation during Drosophila optic lobe development. Society for Neuroscience 36th Annual Meeting, Atlanta, Ga., October 2006.
PROJECT: The effect of Darifenacin on overactive bladder in female and male rabbits SPONSOR: Novartis Pharmaceutical Co. TOTAL GRANT: $27,000 PROJECT PERIOD: 2006-2007
Carlos Feleder Feleder C. The role of the spleen in the febrile response. The University of Buenos Aires School of Medicine, Buenos Aires, Argentina, July 2006.
PROJECT: In vivo correlation of blood flow and pO2 measurements with bladder function SPONSOR: The Institute for Bladder and Prostate Research TOTAL GRANT: $23,000 PROJECT PERIOD: 2007-2008
William R. Millington PROJECT: Pharmacotherapy for opiate addiction and toxicity SPONSOR: National Institute on Drug Abuse TOTAL GRANT: $90,929 PROJECT PERIOD: 2004-2006 PROJECT: Mechanism of action of the β-endorphin derived peptide glycyl-glutamine in the prevention of morphine dependence SPONSOR: Scientific and Research Council of Turkey PRINCIPAL INVESTIGATOR: Sinan Cavun TOTAL GRANT: $90,000 PROJECT PERIOD: 2006-2009 PROJECT: Inhibition of alcohol intake by a non-opioid peptide SPONSOR: National Institute on Alcohol Abuse and Alcoholism PRINCIPAL INVESTIGATOR: Garth Resch TOTAL GRANT: $300,000 PROJECT PERIOD: 2003-2006 PROJECT: The systemic inflammatory response to pathogens in the brain SPONSOR: Albany College of Pharmacy Intramural Grant PRINCIPAL INVESTIGATOR: Carlos Feleder TOTAL GRANT: $4,900 PROJECT PERIOD: 2006-2007
Jeffrey M. Voigt PROJECT: Modulation of AP-1 activity by 1,25-Dihydroxyvitamin D3, VDUP1 and Thioredoxin SPONSOR: Albany College of Pharmacy Blythe Grant TOTAL GRANT: $20,000 PROJECT PERIOD: 2004-2007 PROJECT: The regulation of p53 by VDUP-1 SPONSOR: Albany College of Pharmacy Intramural Grant TOTAL GRANT: $4,000 PROJECT PERIOD: 2006-2007
A B ST R A C T S / P R E S E N TAT I O N S Mehdi Boroujerdi Goel V, Lee DYW and Boroujerdi M. Influence of modulation of P-glycoprotein and inhibition of CYP3A4 on the pharmacokinetics and bioavailability of Puerarin. American Association of Pharmaceutical Scientists Annual Meeting, San Antonio, Tex., October-November 2006. Zhang T, Lee DYW and Boroujerdi M. Comparative evaluation of pharmacokinetics of Silybin A and Silybin B. American Association of Pharmaceutical Scientists Annual Meeting, San Antonio, Tex., October-November 2006. Prashant Chikhale Birnby L, Murugesan S, Chichester P, Linhardt RJ and Chikhale PJ. Anticancer activity of a novel glycosaminoglycan, acharan sulfate against brain tumor cells. 33rd Controlled Release Society’s International Symposium, Vienna, Austria, July 2006. Fenton II JW, Brezniak DV, Chikhale PJ and Moon DG. Statins and thrombogenesis. XXII World Congress of the International Union of Angiology, Lisbon, Portugal, June 2006. Nornoo A and Chikhale PJ. Microemulsion-based formulations of paclitaxel (PAC): Anticancer activity against rat glioma cells and intestinal permeability. American Association of Pharmaceutical Scientists Annual Meeting, San Antonio, Tex., November 2006.
Feleder C. Afferent and efferent signaling during the inflammatory response. The Favaloro Foundation and University, Buenos Aires, Argentina, July 2006. Feleder C. From the liver to the brain: The role of complement. The National University of La Plata School of Pharmacy, Buenos Aires, Argentina, July 2006. Yilmaz MS, Göktalay G, Millington WR and Feleder C. The initial fall in arterial pressure evoked by lipopolysaccharide is mediated by the preoptic anterior hypothalamic area. Society for Neuroscience, Atlanta, Ga., October 2006. Feleder C, Yilmaz MS, Göktalay G and Millington WR. Neither vagotomy nor pentoxifilline inhibit a high dose lipopolysaccharide (LPS)induced hypotension in rats: possible role of a central mechanism. Society for Neuroscience, Atlanta, Ga., October 2006. Robert M. Levin Levin RM. Ischemic etiology of obstructive bladder disease. Taiwan National Continence Society Meeting ,Taiwan National University, Taipei, Taiwan, October 2006. Levin RM. Current research topics in urology. Taiwan National Continence Society Meeting,Taiwan National University, Taipei, Taiwan, October 2006. Levin RM. Biomarkers for obstructive bladder dysfunction. Taiwan National Continence Society Meeting, Taiwan National University, Taipei, Taiwan, October 2006. Levin RM. The effects of cycical estrogen on the lower urinary tract. International Continence Society, Christchurch, New Zealand, November-December 2006. Levin RM. Effect of Letrozole on female rabbit urinary bladder function. American Urological Association Meeting, Anaheim, Calif., May 2007. Levin RM. Effect of castration on male rabbit lower urinary tract tissue enzymes. American Urological Association Meeting, Anaheim, Calif., May 2007. Levin RM. Effect of age on the response to partial bladder outlet obstruction in rabbits. American Urological Association Meeting, Anaheim, Calif., May 2007. Levin RM. The effect of partial bladder outlet obstruction on carbonyl and nitrotyrosine distribution in male rabbits. American Urological Association Meeting, Calif., May 2007. Levin RM. Long term partial bladder outlet obstruction induced contractile dysfunction in male rabbits: A role for Rho-Kinase. American Urological Association Meeting, Anaheim, Calif., May 2007. William R. Millington Yilmaz MS, Göktalay G, Millington WR and Feleder C. The initial fall in arterial pressure evoked by lipopolysaccharide is mediated by the preoptic anterior hypothalamic area. Society for Neuroscience, Atlanta, Ga., October 2006. Feleder C, Yilmaz MS, Göktalay G and Millington WR. Evidence that activation of the vagus nerve initiates the fall in arterial pressure evoked by low, but not high, dose lipopolysaccharide. Society for Neuroscience, Atlanta, Ga., October 2006. Adwoa O. Nornoo Nornoo AO, Owusu-Obeng A, Myer BS, Nguyen H and Reed R. Effect of oral microemulsions on the permeability of paclitaxel across rat GIT and caco-2 cell monolayers. American Association for Cancer Research Annual Meeting. Los Angeles, Calif., April 2007. Jeffrey M. Voigt Snyder RG, Levendusky MC, Voigt JM, and Dearborn Jr. RE. Sustained expression of the vitamin D3 up-regulated protein 1 (VDUP-1) tumor suppressor correlates with the glial subtype differentiation during Drosophilia optic lobe development. Society for Neuroscience Annual Meeting, Atlanta, Ga., October 2006. Haian Zheng Xie X-Q, Zheng H, Zhao J, Chen J and Zhang Y. Transforming marijuana receptors to a gold target: GPCR membrane protein NMR. 62nd Southwest Regional Meeting of the American Chemical Society, Houston, Tex., October 2006.
Albany College of Pharmacy PRESIDENT’S REPORT 2007
Robert M. Levin PROJECT: Ischemic etiology of obstructive bladder dysfunction SPONSOR: National Institutes of Health TOTAL GRANT: $1,132,546 PROJECT PERIOD: 2004-2008
ACPPresRepFINAL
4/4/08
3:58 PM
Page 38
Arts and Sciences P U B L I C AT I O N S
A B ST R A C T S / P R E S E N TAT I O N S
Kenneth J. Blume Blume KJ. Review of Tom Chaffin’s Sea of Gray:The Around the World Odyssey of the Confederate Raider Shenandoah. H-Maritime (http://www.h-net.org/~maritime/), October 2006.
Kenneth J. Blume Blume KJ. The talented tenth and American foreign policy: African Americans in the U.S. diplomatic corps, 1865-1914. The Shaping Role of Place in African American Biography Conference, Massachusetts College of Liberal Arts, North Adams, Mass., September 2006.
Blume KJ. Review of George Matteson’s Tugboats of New York: An Illustrated History. Steamboat Bill: Journal of the Steamship Historical Society of America 260, Winter 2006. Blume KJ. Review of Eric Paul Roorda’s Cuba, America and the Sea. International Journal of Maritime History 18(2):501, December 2006. Margaret Carroll Carroll M. Review of John McGahern’s Memoir, The Canadian Journal of Irish Studies, January 2007. Ray Chandrasekara Chandrasekara R. Politics of madness and the dreamscape of modernity in Yokomitsu Riichi’s Japan. International Journal of Humanities 4(3):4554, 2006. J. Daniel d’Oney d’Oney JD. “Louisiana’s Old State Capitol Museum: Castle on the Mississippi” in Defining Memory: Local Museums And the Construction of History in America’s Changing Communities (Amy K. Levin, ed.). Lanham, Md.: Altamira Press, 2007:77-91. d’Oney JD. Review of Steamboats as Agents of Change in the American and Canadian Wests. Journal of the West 45(4): 71-74, Fall 2006 d’Oney JD. Review of Charles Weeks’Paths to a Middle Ground; the Diplomacy of the Natchez, Boufouka, Nogales, and San Fernando de las Barrancas, 1791-1995. American Indian Culture and Research Journal 30(3), 2006. d’Oney JD. Review of Shadowcatcher:The Life and Work of Edward S. Curtis. Journal of the West 45(4), Fall 2006. Kevin M. Hickey Hickey KM. Furrowing Africa’s killing fields. International Journal of the Humanities. 4(5):101-109, 2006. Hickey KM and Karatsolis A. Interactive learning: Using tablet PCs and DyKnow to foster learning communities. Proceedings of the International Conference on Information Communications Technologies in Education 2006 (Ken Fernstrom and Kostas Tsolakidis, eds.). Abbotsford (Canada): University College of Fraser Valley Press, 2006: 379-383. Marion Jacobson Jacobson M. “From Communism to Yiddishism: The reinvention of the Jewish People’s Philharmonic Chorus of New York City” in Chorus and Community (Karen Ahlquist, Ed.) University of Illinois Press, 2006. Jacobson M. “Communal Choirs” in The YIVO (Yiddish Institute for Jewish Research) Encyclopedia of Jews in Eastern Europe (Gershon Hundersted, ed.), New Haven:Yale University Press, 2007. Andreas Karatsolis Karatsolis A and Hickey KM. Interactive learning: Using tablet PCs and DyKnow to foster learning communities. Proceedings of the International Conference on Information Communications Technologies in Education 2006 (Ken Fernstrom and Kostas Tsolakidis, eds.). Abbotsford (Canada): University College of Fraser Valley Press, 2006: 379-383. Michael Pittman Pittman M. Gurdjieffian laughter: Demolition and reconstruction in Beelzebub’s Tales. Proceedings of the 11th International All and Everything Conference (Ian MacFarlane, ed.), Charleston, S.C.: BookSurge Publishing, January 2007.
Blume KJ. Growing up Catholic in a Protestant profession: Richard Worsam Meade III, his naval career and his faith. Spring meeting of the American Catholic Historical Association, Marquette University, Milwaukee,Wis., March 2007. Blume KJ. Shipping toward the 21st century (session chair). Annual meeting of the North American Society for Oceanic History, U.S. Merchant Marine Academy, Kings Point, N.Y., May 2007. Blume KJ. Who needs to know about the Schlieffen Plan?: Focusing on the “Big Picture” and World War I. Annual meeting of the World History Association, University of Wisconsin, Milwaukee, Wis., June 2007. Margaret Carroll Carroll M. Changing Ireland mirrored in fiction: The short stories of John McGahern. New England American Conference for Irish Studies, University of Connecticut, Storrs, Conn., October 2006. Ray Chandrasekara Chandrasekara R. Negotiating the sublime: Islam in the Malay world. New York Conference on Asian Studies, St. Lawrence University, Canton, N.Y., October 2006. Chandrasekara R. Politics of madness and the dreamscape of modernity in Yokomitsu Riichi’s Japan. Fourth International Conference on New Directions in the Humanities, Tunis, Tunisia, July 2006. David W. Clarke Dominelli AC, Clarke DW, Reed T, Flint RW, Papandrea D and Khan S. The impact of pharmaceutical education on attitudes and knowledge of direct-to-consumer advertising. Annual Meeting of the Society for Medical Decision Making, Boston, Mass., October 2006. Clarke DW. The use of drug salts to illustrate physical and chemical properties in general chemistry. 2006 Annual Conference of the Science Teachers Association of New York State, Ellenville, N.Y., November 2006. J. Daniel d’Oney d’Oney JD. Collective memory in the Houma Nation of Louisiana. Southern Anthropological Society, Oxford, Miss., February 2007. d’Oney JD. Fort Adams, Mississippi, and St. Patrick’s Catholic Church: A case study in appropriation of native history. American Society for Ethnohistory Conference, Williamsburg, Va., November 2006. Kevin M. Hickey Hickey KM. Land and the cultivation of African nationalisms in Véronique Tadjo and Yvonne Vera. National Endowment for the Humanities Colloquium on Africa and the Americas, Westchester Community College, Valhalla, N.Y., December 2006 Hickey KM and Karatsolis A. Interactive learning: Using tablet PCs and DyKnow to foster active learning communities. International Conference on Information Communication Technologies in Education Conference, Rhodes, Greece, July 2006. Hickey KM. Love memory reaching out: Furrowing Africa’s killing fields. Fourth International Conference on New Directions in the Humanities, Tunis, Tunisia, July 2006. Hickey KM and Dodson H. Research collections and methods. National Endowment for the Humanities Colloquium on Africa and the Americas, New York, N.Y., September 2006.
ACPPresRepFINAL
4/4/08
3:59 PM
Page 39
P 39
Karatsolis A. A national online essay evaluation service: A celebration of its history and success. Learning Without Barriers/Technology Without Borders: Celebrating the MIT Microsoft iCampus Alliance, Cambridge, Mass., December 2006. Karatsolis A. Tablet PCs in the writing classroom: The shift to information design. Writing, Teaching and Technology conference, University of Massachusetts, Amherst, Mass., April 2007. Karatsolis A. Expanding the territory of WAC: Visual communication in the writing classroom. 2007 Conference on College Composition and Communication, New York, N.Y., March 2007. Karatsolis A. Tablets as writing canvases and construction sites. Workshop on the Impact of Pen-based Technology on Education, Purdue University, West Lafayette, Ind., June 2007. Karatsolis A. Tablet PCs and higher education: Are they made for each other? Workshop on the Impact of Pen-based Technology on Education, Purdue University, West Lafayette, Ind., June 2007. Karatsolis A. DyKnow in Communication classrooms. DyKnow User Group Meeting, DePauw University, Greencastle, Ind., June 2007. Erika A. Muse Muse E. The Bible in Chinese Christian America: Scripture and the construction of ethnicity, community and tradition. American Anthropological Association 105th Annual Meeting, San Jose, Calif., November 2006. Muse E. Contentious divides and the legislation of morality: Defining homosexuality, traditional marriage and civil rights among Chinese Christians of Massachusetts. Democracy and its Discontents: Religion and the Underside of Pacific Asian North American Religion, Asian Pacific Islander Religious Research Initiative Annual Meeting, University of California, Berkeley, Calif., August 2006. Laura Rogers Rogers L. I just want someone to know I was here: Incarcerated writers and re-presentations of identity. Conference on College Composition and Communication, New York, N.Y., March 2007. Rogers L. Our little red book: Tutors’ journals as keys to institutional tensions. Northeast Writing Centers Association, Nashua, N.H., April 2006. Rogers L. The use of tutor journals. Hudson Valley Writing Center Directors’ Association, Maria College, Albany, N.Y., May 2006. Sandra K. Winn Winn SK. Drawing identities: How students, teachers and administrators re-design expectations and themselves through tablet PC technology. Conference on College Composition and Communication, New York, N.Y., March 2007.
GRANTS Kevin M. Hickey PROJECT: Attendance at Africa and the Americas Colloquia,Westchester Community College SPONSOR: National Endowment for the Humanities TOTAL GRANT: $500 PROJECT PERIOD: July, September and December 2006 JURIED EXHIBITIONS Lisa E.Vines Vines LE. “Virginia Spring,” Tri County 24th Annual National Small Works exhibit (juror Lori Bookstein), Cobleskill, N.Y., July-August 2006.
Albany College of Pharmacy PRESIDENT’S REPORT 2007
Andreas Karatsolis Karatsolis A and Hickey KM. Interactive learning: Using tablet PCs and DyKnow to foster active learning communities. International Conference on Information Communication Technologies in Education Conference, Rhodes, Greece, July 2006.
ACPPresRepFINAL
4/4/08
3:59 PM
Page 40
Department of Health Sciences GRANTS Indra Balachandran PROJECT: Fine needle aspiration cytology using Monogen Monoprep速 methodology SPONSOR: Monogen Corporation, Chicago, Ill. TOTAL GRANT: $2,975 PROJECT PERIOD: March 2007-September 2007 PROJECT: Creation of an on-line comprehensive cytopathology review course with evaluation for the benefit of cytopathology students, professionals and pathology residents SPONSOR: Scholarship of Discovery and Educational Excellence Grant, Albany College of Pharmacy TOTAL GRANT: $3,550 PROJECT PERIOD: May 2007-June 2008
Victoria Peters PROJECT: Development of computer simulation for clinical chemistry curriculum SPONSOR: Scholarship of Discovery and Educational Excellence Grant, Albany College of Pharmacy, Albany, N.Y. TOTAL GRANT: $3,000 PROJECT PERIOD: June 2006-May 2007 A B ST R A C T S / P R E S E N TAT I O N S Indra Balachandran Balachandran I and Walker J. Cyto Boot Camp: A comprehensive review for board examinations. Albany College of Pharmacy, Albany, N.Y., August 2006. Balachandran I. Board review for CT and SCT certification exams. M.D. Anderson Hospital, Houston, Tex., August 2006. Balachandran I and Stowell S. Entering the real world: Job outlook/employer expectations. American Society of Cytopathology Annual Meeting, Toronto, Canada, November 2006. Balachandran I. Interesting cases: A neuron challenge. Albany College of Pharmacy, Albany, N.Y., December 2006. Balachandran I. State Licensure: Lessons to learn from the New York State experience. Papanicolaou Conference, M.D. Anderson Hospital, Houston, Tex., May 2007. Balachandran I. Board review for CT and SCT certification exams. M.D. Anderson Hospital, Houston, Tex., May 2007.
* Deceased Bolded names indicate ACP faculty collaborators
Page 41 3:59 PM 4/4/08 ACPPresRepFINAL
P 41
Albany College of Pharmacy PRESIDENT’S REPORT 2007
ACPPresRepFINAL
4/4/08
3:59 PM
Page 42
Financials
Balance Sheet
ASSETS Cash and Cash Equivalents Investments Other Assets Accounts Receivable—Students Receivables—Government Entities Other Receivables Pledges Receivable Student Loans Receivable Agency Funds Deposits with bond Trustess Property,Plant & Equipment—Net Total Assets LIABILITIES AND NET ASSETS Liabilities Line of credit Accounts payable and accrued liabilities Deferred income and deposits U.S. government grants refundable Bonds Payable Capital lease obligation Expected Post Retirement Benefit Obligation Deposits held in custody for others Total Liabilities Net Assets UNRESTRICTED: For current operations Funds functioning as an endowment Plant Fund Total Unrestricted Net Assets TEMPORARILY RESTRICTED: Unexpended funds received for restricted purposes College matching contribution to student loans Total Temporarily Restricted Net Assets PERMANENTLY RESTRICTED: Endowment Funds O’Brien Loan Fund Total permanently restricted net assets Total Net Assets Total Liabilities and Net Assets
$
$
$
$
$
$
$ $
$
$
9,353,143 11,042,629 2,131,879 724,688 1,325,480 1,078,196 619,291 2,363,530 163,483 1,296,392 42,317,471 72,416,182
3,868,827 1,928,908 8,555,434 2,105,992 22,416,485 10,191 734,046 163,483 39,783,366
2,623,291 4,492,985 19,615,015 26,731,291
1,065,638 331,740 1,397,378
4,470,093 34,054 4,504,147 32,632,816 72,416,182
ACPPresRepFINAL
4/4/08
3:59 PM
Page 43
P 43
Albany College of Pharmacy PRESIDENT’S REPORT 2007
Operations
REVENUES Student Tuition and Fees
72.78%
Government Contracts and Grants
9.58%
Auxiliary Enterprises
8.91%
Investment Income
4.95%
Gifts and Pledges
2.47%
Other Sources
0.92%
Postgraduate Education
0.38%
EXPENSES Instruction/Student Services
39.78%
Physical Plant
25.59%
General Administration
17.98%
Research
10.98%
Institutional Advancement
3.65%
Student Financial Aid
1.47%
Postgraduate Education
0.55%
ACPPresRepFINAL
4/4/08
3:59 PM
Page 44
Gifts and Donations
Albany College of Pharmacy gratefully acknowledges the generous support received from alumni, corporations,foundations,faculty,staff,administrators, friends and parents.Whether through a gift to the Annual Fund, sponsorship of a flag at the Dean’s Cup golf tournament, underwriting an event or a gift to a scholarship fund, this support helps to make possible ACP’s dedication to the preparation and education of students for the practice of pharmacy and health care professions.
ACPPresRepFINAL
4/4/08
3:59 PM
Page 45
P 45
Giving Clubs
William Mansfield Circle $5,000 – $9,999 Michael F. Bette + Brooks/Eckerd Pharmacy J. Gordon Dailey ’57 + Kandyce J. Daley ’74 + Envision Architects PC Follett Higher Education Group Gateway Companies Hugh A. Johnson Jr.+ Gerald H. Katzman Thomas O. Maggs + Virginia M. McBride ’53 Robert F. McGaugh ’57 + Ruth Peckham Richard G. Robison ’52 + Rose and Kiernan, Inc. Carol Ju & David M. Rubin Francis M. Steed ’53 TD Banknorth N.A. Carolyn White Willis Tucker Circle $2,500 – $4,999 Abbott Laboratories Bette & Cring, LLC Robert S. Busch + ComDoc, Inc. Richard H. Daffner ’63 + Christopher ’88 + & Sara L. ’91 DelVecchio Rinaldo V. DeNuzzo ’52 Geno J. ’83 & Theresa B. ’86 Germano Jr. Ellen L. Kennett ’91 Josie Leighton Marion T. Morton ’84 National Association of Chain Drug Stores Foundation nfrastructure Robert E. L. Nesbitt Publix Super Markets Charities, Inc. QS/1 Data Systems Sodexho Inc. & Affiliates Dexter B. Spaulding ’58 Troy D. Spaulding ’85 Time Warner of Albany, N.Y. Alan P. Tubbs ’54 Wal*Mart Stores, Inc. Founder’s Society $1,881 – $2,499 Nick G. Anagnost ’57 James E. Bollinger ’58 + Lucille Cerro Selig D. Corman ’58 Vicki A. DiLorenzo Edward A. ’59 & Dorothy M. ’62 Fausel
Andrew G. ’87 & Kelly L. ’89 Flynn Jon J. Gallagher ’62 GE Foundation Zachary I. Hanan ’63 + Krackeler Scientific, Inc. William ’66 & Kathleen ’66 Quackenbush III Dominic & Tina Raco # Joseph S. Rebisz ’70 Gregory J. Sciarra ’93 Larry E. Small ’71 Stulmaker, Kohn & Richardson Wyeth Archibald McClure Circle $1,000 – $1,880 (^ Indicates alumni out 10 years or less who have given $500 to $1,000) Accent Commercial Furniture, Inc. Anonymous Thomas Babcock Investment Advisers LLC Bank of America Nicholas Barbuto Jr. Frank C. Berning ’67 Raymond A. Bleser ’81 Mehdi Boroujerdi Robert H. Brakemeier ’65 Leigh Briscoe-Dwyer ’87 David R. Brooks ’67 Thomas E. Byrnes ’57 Donald R. Charles Jr. ’67 Robert ’76 & Glynis ’75 Clark Alfred J. Collins Jr. ’53 + John R. ’70 & Lynne K. ’69 Cote David P. DeMagistris ’77 Kim ’75 & Rose Mary ’75 Demers John J. Denio Albert L. DiDonna ’65 Francis J. DiLascia ’54 + August J. Dobish ’59 Eli Lilly and Company Mark W. Fagnan ’97 ^ Jane W. Fox ’68 Rocco F. Giruzzi Jr. ’58 GlaxoSmithKline, Inc. Anthony J. Graziano ’84 David A. Hanson ’59 Bridget-ann Hart ’80 + James J. & Gloria Hunter InterfaceFlor Commercial Johnson Illington Advisors, LLC David M. ’74 & Susan M. ’74 Kile Joseph M. Lapetina + Marcia M. Locke ’73 Mabey’s Moving & Storage, Inc. Ralph T. ’59 & Mary Lou ’60 Mancini Markel Insurance Company John M. Marraffa Jr. ’03 ^ Mary Beth Marten ’03 & Teryl A. Romeo ’03 ^ John F. McCarthy ’58 Stephen I. Michaelson ’58 Jack A. Monakey ’53 Stephen B. Morgan ’70 Shaker A. Mousa David J. Muller ’73 James W. Nowicki ’62 Suzette A. Pablo ’06 ^ Henry A. Palmer ’57 Ann Parillo ’57 Vincent A. Pigula ’74 Carol R. Powell ’60
Bertram A. Rapowitz ’58 RBC Capital Markets James J. Roome Jr. ’79 Howard A. Rubinger ’63 John Savoy and Son, Inc. Neil T. Schram ’67 Howard J. Slater ’47 William R. Steed ’57 Larry G. Tabor ’88 Scott Terrillion ’85 Michael G. ’00 & Trisha A. ’00 VanDerwerken Frances Verderame Patricia S. Wilson ’83 John M. Woychick Pharmacy Associates $500 – $999 Anthony Albano ’57 American Eagles G. B. C. Jeremiah S. Axtell ’90 Allen Barnett Brian W. Bartle ’62 Sam F. Berardino III ’80 James W. Bevilacqua ’79 Elke M. Blaetz ’92 Alan Blum ’69 Robert A. ’83 & Bonnie B. ’83 Blum Kathleen E. Bonnier ’91 J. Mark Bover ’83 Jack E. Boylan ’57 Scott W. Brown ’54 James P. Byrnes ’66 Cardinal Health Nicholas ’65 & Nancy ’65 Chervinsky Anthony Chiffy Sr. ’60 Richard A. Cognetti ’69 William G. Davis ’70 Thomas & Lynne DellaRocca H. Russell Denegar ’43 Christopher J. DiLascia ’83 Express Scripts/Value Rx John J. Faragon ’96 Philip ’87 & Barbara ’88 Favreau Rocco Femia Sr. ’60 Warren D. Ficke ’59 Frank C. Flannery ’66 Angelo M. Friello ’57 Gregory P. ’71 & Barbara H. ’72 George Mark Gersten ’81 Thomas P. Gillette ’65 Mary Ann D. Godlewski ’72 Lewis Golub Marilyn S. Green ’57 Lewis Barton Helfstein ’68 Rick N. Hogle ’76 William C. Irwin ’81 J M T Brokerage, Inc. Michael B. Julius ’72 Sally Ann Kay Leon N. Kentner ’81 David M. ’74 + & Susan M. ’74 Kile David S. Knightes ’69 Stephen & Elaine Kovary # David A. Kvancz ’79 John P. LeGrand ’70 Michael B. Levine ’72 Tiffany I. Loder ’93 Arthur J. Macarios ’57 Patrick S. McGraw Elsie W. Mulrooney ’57
Novartis U.S. Foundation Barbara J. Olchek ’69 Philip R. Palumbo ’66 Pfizer, Inc. Wallace B. Pickworth ’69 William J. Reilly ’57 Barry S. Reiss Gregg W. Richmond ’72 Mary Anne Ross Gary J. Salamido ’86 Thomas M. Sands ’66 Janis E. Scott ’59 William ’68 & Maryann ’70 Sheeley Elinor W. Smith ’62 Regina G. Snyder ’47 Richard E. Sobiski ’65 Reid H. Sperber Edgar V. Stevens ’67 Tech Valley Communications Robert & Marian Tompkins # Tamara H. Turner ’88 Frank A. Viviani ’58 John T. Westerman Jr. ’78 Ronald Winchell ’65 Barry F. Wishengrad ’61 Wayne F. Woodcock ’57 A. John Wylie ’68 Rolf ’79 & Beverly ’79 Zakariassen Richard J. Zalewski ’74 Mortar & Pestle $250 – $499 Action Window Cleaning Co., Inc. Allen’s Upholstery and Carpet Cleaning Ronald A. Amedio ’65 American Chemical & Equipment Co. Audio Video Corporation Alfred A. Austin Jr. ’97 Darrell S. Barber ’78 Jolene R. Bates ’81 Charles J. Bernas ’57 Kathleen Bibbo ’80 Steven L. Blakeslee ’68 John A. Bottiroli ’61 David & Catherine Bousquet # Joseph R. Burgess ’72 Burkins & Foley Trucking and Storage, Inc. Shelly A. Calabrese Christopher J. Klein ’85 & Jennifer Caloia ’86 Christine V. Camille ’86 Michael J. Canale ’76 Capital Area Pharmacists Society Francis A. Carbone ’63 David J. Carpenter ’81 Joseph Chiffy ’94 Chubb Esten Coan ’52 Elliot Cohen ’58 Colonie Mechanical Contractors, Inc. Philip W. Cornell ’69 W.L. Coughtry/Dataflow Joanne Criscione McTague ’76 William M. Cronin Burton F. Deis ’79 Mark A. Desieno ’86 The Desmond Warren E. Doetsch ’58 Angela C. Dominelli ’78 S.J. Dooling Building & Remodeling
Albany College of Pharmacy PRESIDENT’S REPORT 2007
President’s Circle $10,000 & Above Albany Law School CVS Anonymous Melvin S. Friedland ’58 + James J. Gozzo Harry Mikhitarian ’54 Memorial Fund Kinney Drugs Foundation, Inc. Fouad & Amal Morkos # Pepsi Rite Aid Corporation The Robison Family Foundation Walgreens
ACPPresRepFINAL
4/4/08
3:59 PM
Kenneth P. Drabik ’74 Corey J. Duteau ’97 Envision Communications Consultants, LLC John N. Erb ’66 Excel Systems, Inc. Richard P. Fernandez ’60 Kevin J. Fessler ’99 Michael P. Flannery ’01 Flooring Environment, Inc. John D. Forman ’52 Louis J. Fratto Jr. ’74 Jan Frodyma Peter S. Gage ’81 William Galarneau ’76 Sanjay N. ’95 & Ursula ’96 Gandhi Thomas P. ’83 & Teresa ’83 Garcia Santo Anthony Garro ’60 L. Thomas ’92 & Maureen ’92 Geiser William Gonz ’56 Gale L. Gridley ’63 William O. ’85 & Dorothea A. ’83 Griffiths Mary E. Haggard ’83 Frederick S. Haggerty ’50 Owen W. Halloran ’75 Heslin Rothenberg Farley & Mesiti P.C. Hession Electric, Inc. Higher Education Marketing Associates, Inc. Hiscock & Barclay, LLP R. Gary ’72 & Olesia A. ’75 Hollenbeck Philip M. Hritcko ’83 J C B Specialties, Inc. KONE, Inc. Maya Kurtz ’85 Jeanette S. Lamb ’57 + David Langley Richard R. Little ’66 Edward A. Loeber ’80 Frederick J. Macri ’74 Mahoney Notify-Plus Inc. Theologos Malahias ’82 Marilyn A. Mc Carthy ’54 Sean F. McCarthy ’83 John T. McDonald III ’85 James ’82 & Marian ’82 McLaughlin Patrick J. McLaughlin ’86 Angelo A. Mercurio ’51 Merrill Lynch & Co., Inc. Nicholas Mesiti Frederick G. Miller ’81 Milliman Consultants & Actuaries William R. Millington Edward P. Molloy ’62 James E. Monahan ’76 Moore Fire Extinguisher Company LLC Philip P. Moyer ’70 Arthur W. Muldoon ’72 Martha Naber ’86 Thomas H. Neely ’71 Jeffrey A. Newell ’80 Harry P. Norman ’61 Amanda K. Nuzzo ’99 Colleen H. O’Malley ’81 Patricia F. Osowick P & G Fund Mark ’82 & Karla ’91 Palmer Carolyn A. Peebles ’85 Henry C. Miller ’74 & Nancy Phillips ’74 Darren M. Pynn ’88 Mark J. Quackenbush ’79
Page 46
RBM Guardian Fire Protection, Inc. Richard D. Robertello ’84 Robinson Hall Architectural Roche Ronald V. ’96 & Brandi L. ’96 Romano John E. Romeo ’86 Richard A. Rubin ’61 Robert M. Santimaw ’61 Saxton Signcorp Robert C. Schmitt ’52 Sentron Associates, Inc. Stephen R. Shearer ’82 Christine Shields James V. Skelly ’82 Robert G. Single ’69 Thomas B. Snow ’71 Sonitrol of Albany Kim L. Sprague ’78 Stanley R. Stankes ’50 Stants Combustion Assoc., Inc. Robert M. Stote ’60 Garen Szablewski ’81 Technical Building Services Philip Teicher ’51 Tracey J. Toner ’95 TurfLinks, Inc. Ruth-Ellen Van Arnam ’94 David B. Van Etten ’61 Elwin E. VanValkenburg ’52 Diane Vincent Doris R. Voigt ’69 John ’70 & Maria ’70 Wakefield WeatherGuard Roofing Co. Thomas D. Weaver Mark L. Williams ’58 Walter ’51 & Eleanor ’54 Williams Christine M. Wood ’78 David J. Zdunczyk Giuseppe & Maria Zeolla Mario M. ’97* & Christine M. ’99 Zeolla Maroon & White $100 – $249 Ace Pest Control Specialists, Inc. Maryjane Aiello ’78 Richard K. Aikens ’63 Jacqueline A. Aldershoff ’85 Thomas W. Algozzine ’93 Amgen Foundation William B. Amsden ’59 James L. Anderson Judson Anderson ’02 Kelly L. Anderson ’98 Lee A. Anderson ’66 Sidney C. Anderson ’87 Richard S. ’92 & Tracey L. ’92 Andrews Harvey M. Arbit ’70 Ellen M. Aschbrenner ’90 Anne E. Astemborski ’85 Daniel M. Astry ’77 Henry C. Aumiller ’38 Maria O. Bachynsky ’67 P. Edgar Badgley ’57 Indra Balachandran Pradip & Sukla Barat # Debra L. Barber ’88 G. Wesley Barnard ’58 Jennifer L. Battin ’86 Deborah R. Bauman ’79 Lisa A. Baumander ’94 Richard D. Baylis ’61 James H. Beatson ’60 Judith M. Beaulac ’72 Bradd J. Beimford ’96 Edward A. Belemjian ’52 Michael E. Belemjian ’75 David J. Bendyk ’83
Henry R. Bennett ’31 Stuart A. Berney ’69 Alan M. ’92 & Cory A. ’92 Bernstein Richard A. Billington ’87 Annabelle S. Bink ’95 Dominick A. Bizzarro ’87 Jason M. Blitz ’02 Nicholas S. Bonarrigo ’65 Lisa E. Bonner ’80 Holly M. Bonsignore ’82 Jeffrey L. Bookhout ’78 Robert D. Boroujerdi Pamela M. Bowers ’89 Ann Marie Z. Bowman ’70 Jane K. Boyd ’82 David C. Brands ’68 Joseph L. Breton ’99 John ’72 & Sheila ’72 Briglin Cynthia L. Brown ’84 Fred ’77 & Marylourdes ’77 Brundige Brian ’96 & Stacey ’96 Bruyns Nicole A. Bulmer ’04 Larry M. Burling ’70 Norman & Shirley Burman # Edward L. Burns ’55 Julie K. Burns ’82 Michael ’80 & Jane ’81 Butler Donald H. Butlien ’52 Frank Capristo, Jr. ’70 Anne T. Carlisto ’85 Patricia B. Carney ’51 Alan J. Carpenter ’67 Lawrence J. Casey, Jr. ’64 Brian M. Carroll ’79 Fred A. Carroll III ’82 James D. Cataldi ’99 Jean B. Chambers ’46 Walter ’52 & June ’55 Cherniak Albert G. Chmura ’69 Gilbert Chorbajian Herbert G. + & Linda Chorbajian Daniel & Jeanne Ciampino # Richard F. Cimildoro ’68 Carol A. Ciufo ’57 David C. ’76 & Maura B. ’76 Clark Michael ’86 & Sandra ’87 Clarke Joseph A. Colangelo ’76 Donald T. Collea ’91 Michael E. Collins ’78 Timothy C. Colyer ’65 Ralph N. Comanzo ’58 Joseph A. Comito ’91 Susan K. Conklin ’94 Rebecca A. Conrad ’99 Paul F. Consroe ’66 Ann Marie Conti-Kelly Greco ’73 Kevin & Sally Cope # Samuel A. Coppola ’55 Jill M. Corbett ’89 David R. Corina ’52 Stephen C. Corson ’79 Baird C. Couch ’62 John C. ’00 & Tracey L. ’01 Coultry Robert J. Craner ’70 Phyllis Cristo Pomeroy ’61 Everett D. Cronizer ’87 James F. ’87 & Colleen A. ’88 Cross Richard L. Culver ’52 Jaclyn K. Dacier ’91 Susan D. Dahm ’66 Christine M. Daniel ’97 J. Michael ’99 & Nicole ’03 Darbyshire Robert ’89 & Maryanne ’89 Davis Donald & Linda D. Davison # Geraldine A. DeGrazio ’68 William Delahant ’67 Tracey A. Denardo ’85
Carla A. Desrosiers ’85 Joseph M. De Vito ’82 Marlene G. Dickson ’77 Michael J. Dillon ’78 Kelly M. Doan ’94 Sean C. ’88 & Imelda N. ’88 Dobbins Arthur F. Dooley ’49 Joshua J. ’05 & Erin ’03 Dorval Barbara A. Duesler ’81 Michael S. Dufort ’99 Tania M. Durante ’91 William J. Dwyer ’60 Clayton ’90 & Michelle ’91 Edwards David D. Edwards ’65 George M. Ehrmann ’54 Deanna Ennello-Butler Excel Engineering, P.C. Rita A. Fahr ’79 Pat Faragon ’56 James Farrell ’77 Michael C. Federici ’73 Michael ’91 & Michele ’90 Fernandez James J. Finn ’68 William J. Finn ’59 Jeffrey P. Firlik ’74 Joseph Fiscella Jr. ’82 Joseph A. Fiscella Sr. ’53 William B. Fizette ’51 Derek ’94 & Amy ’94 Fluty Thomas F. Flynn Jr. ’56 Arthur L. Forman ’85 Barbara A. Forster ’93 Louis ’58 & Marilyn ’61 Fortin Julie-Ann Fortran ’89 Robert J. Fountaine ’97 James Francese Jr. ’52 John P. Fratto ’78 Gilbert Fudin ’53 William J. Furman ’71 Cynthia S. Gabriels ’60 Bhupendra & Minaxi Gadani # Suzanne J. Gaetano ’68 Robert P. ’92 & Julie M. ’93 Galer Jeffrey C. ’88 & Darlene E. ’88 Garbin John R. George ’81 Irwin C. Gerson Lorie A. Giamartino ’89 Rose Marie S. Godlewski ’72 Stephen T. Godlewski ’65 Herbert T. Goggins Sr. ’59 Steve & Youngna Goh # Howard & Jill Goodkin David M. Goodrich ’69 Benjamin P. Graham ’71 Bernard ’71 & Doreen ’72 Graham Thomas Grandville ’01 James T. Gratch ’79 Martin J. Green Sean P. Greene ’00 Vincent M. Grimaldi Sr. ’62 Deborah A. Grimes ’77 Frank ’74 & Marylee ’74 Grosso Joseph P. Guarino ’74 Anthony & Elizabeth Gugino # Gregory G. Guimond ’87 Christine T. Haack ’76 Theodore J. & Kathleen M. Hahn ’72 Wayne W. Halayko ’80 Donald F. Hall ’59 Gary D. Hall ’57 Lyle B. Hall ’77 Thomas C. Hanley ’48 Steven ’85 & Joyce ’86 Hansel Chris A. Haritos ’86 Sharon K. Harper ’92
ACPPresRepFINAL
4/4/08
3:59 PM
Wayne A. Mabb ’70 Peter W. MacArthur ’78 Maureen E. Mack ’94 Francis X. Magee ’57 Michael L. Maggy ’85 Robert Makofske ’93 Joseph D. Manley ’93 Lockheed Martin Jacob & Mercy Malathu # Paul Mangione Jr. ’88 Arthur G. Margolis ’49 Gerard & Madeline Marinaccio # Richard A. Marra ’60 Bruce D. Martin ’55 Joseph N. Marzo ’80 Lisa Ann Mason ’83 Melvyn Masters ’55 Paul M. Matala ’71 Jacqueline A. Matikiewicz ’92 Constance S. Matthys ’80 Kenneth ’86 & Julie Chang ’86 Maxik Lester E. Maxik ’52 Michael W. ’73 & Deirdre ’77 McEntarfer John D. McGrath ’01 Lynn K. McKinnon ’88 Patricia A. McMahon ’86 Edward J. Mc Nulty ’67 Ronald C. Menard ’61 Catherine Merriman Emerson S. Metzler ’95 Glenn A. Meyer ’84 Kimberly C. Meyer ’92 Ronald & Nancy Michonski # Roxie J. Miles ’70 Kenneth W. Miller Michael ’97 & Katy-Erin ’91 Miller Richard Miller ’50 Robert W. Miller ’59 Theodore L. Mitchell ’80 Lawrence H. Mokhiber ’71 Melvin Mones ’51 Raymond J. Mooney ’59 Frank E. Moreno ’57 Mark E. Morin ’95 Joseph P. Morris ’59 Margaret E. Morris ’94 Kathleen Morse ’78 Lori A. Mosher ’89 Jennifer L. Munoz ’97 Mary E. Murphy ’48 David M. Murray ’74 Scott W. Murray ’86 Thomas J. Natalie ’96 Nancy S. Newkirk ’76 Andrew E. Nielsen ’51 Gregory ’92 & Mary Lou ’91 Notaro Bernard Nowitz ’60 David F. O’Connell ’67 Dennis R. O’Grady ’61 Brendan ’97 & Melissa ’96 O’Hara Francis E. O’Hearn ’63 David M. Oles ’76 Justin & Pamela Orlando # Cathy M. Osborne ’85 John M. Ostrander ’68 Krista A. Pahler ’99 Michele Pallotta ’77 Christopher G. ’86 & Lisa ’85 Palmer Michael ’93 & Lori ’94 Panasci Julius A. Pasquariello ’83 William E. Peck ’90 Andrew R. Perkins Sr. ’56 William A. Petersen ’52 Katherine F. Petrone ’59 Robert ’86 & Becky ’86 Petronio
John Son & Nancy Nga Pham # Pharmacist’s Letter Cynthia F. Phillips ’72 Frank M. Piacente ’72 Frank J. Piccirillo ’57 Frederick G. Pickles ’52 Anne K. Pierson ’51 Samuel T. ’85 & Naomi M. ’85 Piraino Mark E. Pochal ’82 Therese I. Poirier ’77 Andrew M. Polak ’83 P. Ronald Pollack ’63 Eugene R. Ponessa ’53 Karl F. Popp ’73 Dominick J. ’75 & Ingeborg S. ’77 Porco Carl J. Possidente ’99 Robert W. Potenza ’42 Richard & Lori Pratt # Henry K. & Janina Prusaczyk # Irene T. Przylucki ’80 Joanne M. Race ’98 Manuel Ramirez ’91 Joseph G. Rampe ’59 Arthur A. Ramsey ’62 Nancy J. Randall ’91 David A. Reagan ’74 Frank M. Reff ’92 Kristin N. Renzi ’92 Kim M. Reynolds ’93 Ira H. Rheingold ’60 Brian ’79 & Roxanne ’78 Richardson Mark A. Riegelhaupt ’79 Armand Rivers Linda J. Ronk ’73 Robert W. Rozek ’58 Daniel Rubinson ’52 Richard A. Sadekoski ’91 Catherine A. Salvagni ’95 Gary E. Sambrook Jr. ’98 Walter & Geraldine Samselski # Gary M. Sanges ’73 Sandra R. Sansone ’63 Joseph ’78 & Kellie ’82 Sanzone Herbert V. Savage ’51 Robert A. Schaefer ’69 Bernard E. Schallehn John H. Schell ’49 William F. Schlomberg ’80 Howard Schwartz ’48 Matthew ’94 & Diane ’97 Scott James H. Serour ’72 William F. Shangraw ’80 Jerome B. Shapiro ’52 John J. Sheeley Jr. ’63 Jay A. Sherline ’63 Donald A. Sherman ’51 John F. Sherman ’49 Michael S. Sherwood ’86 William L. Shumway ’51 Frederick G. Siegenthaler ’57 Richard A. ’99 & Tanya S. ’99 Sillato David Silverhart ’51 William ’66 & Alice ’66 Sliter Susan E. Smith ’94 Linford A. ’51 & Nancy W. ’51 Snyder Robert A. Sofia ’66 Robert H. Solomon ’62 Erin E. Southwick ’94 Anne M. Sowinski ’86 James R. Spillan ’56 Greg R. ’98 & Michelle M. ’98 Stanley Nancy Ann M. Stellato ’81 Carolyn M. Stock ’93 Shirley C. Stolarski ’74
Lewis W. Sturgess ’53 Timothy D. Suenram ’73 Robert S. Sullivan Jr. ’79 David E. Talarico ’62 Norton W. Taylor ’49 Thomas M. Techman ’62 Laura G. Tepper ’52 Denise C. Thoma ’96 Fred M. Thomas ’66 Jacqueline R. Thomas ’74 Robert W. Thorpe ’51 Leila M. Tibi ’02 Kelly E. Toia ’87 Christopher A. Tomchik ’00 Edward L. Toomajian ’81 Robert M. Toomajian ’62 Kurt ’73 & Carol ’72 Trautmann Edward J. Trnka ’59 David E. Urban ’74 Robert H. Van Vlack ’52 David E. VanValkenburg ’81 John ’81 & Michele ’81 Walker John M. Walts ’59 John T. Ward ’76 William R. Warner ’54 Donna W. Warren ’77 Leo & Julie Waseleski # Marc L. Watrous ’91 WebMD Gretchen S. Welge ’78 Robert West ’52 Mary E. White ’90 Patricia D. White ’79 Karen S. Whitney ’78 Mitchell W. Wilbert ’80 Ronald L. Wilcox ’62 Korey H. Willard ’80 Michael D. Willson ’83 Edward ’54 & Lois ’57 Wind Sheila Winnowski ’64 Leo A. Wisniewski ’72 Jean M. Witkowski ’93 Frank & Melanie Wojak # Edward J. ’61 & Karen A. ’63 Wortley Kathleen M. Wyatt ’88 Cynthia M. Wyman ’80 Cynthia L. Young ’88 Michael ’81 & Kimberly M. ’81 Zebrowski Michael J. Zeolla ’01 Jeffrey M. Zurek ’74
P 47
Albany College of Pharmacy PRESIDENT’S REPORT 2007
James E. Harrington ’54 Jacqueline Harris Sema E. Hart ’83 James R. & Robyn D. Hatch # Frank A. Hempstead ’58 John ’66 & Jane ’66 Henty Laurence S. Herman ’69 Rebecca M. Hilborn ’95 Allison A. Hoff ’95 Miriam L. Hogle ’55 Eugene A. Hoh ’61 Christopher T. Horning ’96 Lisa M. Houk ’80 Diana C. House ’86 Patrick E. ’71 & Patricia A. ’69 Howlett Kenneth A. Hoyt ’96 John C. ’70 & Paula H. ’73 Huebeler Mark A. Hunter ’98 Amy C. Hutchison ’86 Murray P. Hyatt ’56 Fred Isabella ’42* Susan L. Iwanowicz Judy J. Izard ’93 David S. Jackson ’66 Bernard G. Janeczko ’87 Nicole M. Janiszewski ’02 Nicole L. Jareo ’96 Gary P. Johnson ’71 Paul E. Johnson ’84 Edgar L. Jorolemon ’60 Mary Beth Juron ’89 Irmgard S. Kaiser ’48 Sylvia M. Kaminsky ’69 Michael P. ’84 & Teresa H. ’84 Kane Kyoung-Sil Kang ’97 James ’75 & Lorraine ’75 Kewley William & Barbara Kewley # King Venetian Blind & Drapery, Inc. Walter D. Kinnin ’60 John Edward Kirker ’70 L. Jane Klippel ’52 Mathew & Lissy Kochupurackal # Paul F. ’71 & Ellen D. ’71 Koehler Stephen A. Koerts ’71 Bertram L. Kohn ’60 Deborah B. Komoroski ’78 Janet S. Korwan ’81 Melvyn M. Kost ’54 Srividya Kotapati ’01 Arthur ’59 & Jeannie ’59 Kramer Jeffrey H. & Lesia Kurtz # Stephen J. Kwasnik ’90 Philip K. LaFluer Jr. ’94 Paul ’92 & Mary Jo ’92 Lakomski Paul A. Lanciault ’56 Jennifer R. Landaverde ’97 Jill R. Lang ’78 Rose E. Lang ’69 David O. ’89 & Jean A. ’90 Lange Salvatore J. Lanzafame ’55 Ivan S. Law ’99 Susan N. Layne ’61 Laura Le ’99 Matthew D. ’86 & Lynne K. ’86 Lee Roger A. Lemke Jr. ’87 Lawrence E. Lenihan ’69* Edward A. Lenz ’56 Kimberly A. Leonard ’89 Ralph & Donna Leonardi # Ronald E. Lesko Dale R. Lewis ’93 Allen J. Lieberoff ’59 Lea A. Lilie ’79 William J. Lincourt ’55 Paul G. Litynski ’77 Robert J. Locke ’72
Page 47
ACPPresRepFINAL
4/4/08
3:59 PM
Page 48
The Francis J. O’Brien Society
Class Giving
The Francis J. O’Brien Society honors individuals who have made charitable planned gifts or have made known their intentions to include ACP in their wills or estate plans. Donors who have made financial or estate gifts of any size through wills, trusts or other planned gifts are recognized for their dedication to the college’s mission.
1931 Class Size: # of Donors: % of Participants: Henry R. Bennett
2 1 1
1937 Class Size: # of Donors: % of Participants: Joseph Klein
13 1 1
1938 Class Size: # of Donors: % of Participants: Henry C. Aumiller
10 1 1
Alan Blum ’69 Donald R. Charles Jr. ’67 Lucille Cerro John R. & Lynne K. ’ 69 Cote Jack & Kandyce J. ’74 + Daley Edward J. Enos ’84 Warren D. Ficke ’59 John L. Finnegan ’57 Charlotte Helprin Richard F. Isele ’49 Chester Koblantz Bruce D. Martin ’55 Roxie J. Miles ’70 Kenneth M. Nirenberg William F. O’Brien Charles W. Owens ’54 Eugene R. Ponessa ’53 Regina G. Snyder ’47 Daniel Spadaro ’23* Norton W. Taylor ’49 Gino & Willie Turchi
1942 Class Size: # of Donors: % of Participants: Total Gift: Janis L. Best Fred Isabella* Robert W. Potenza 1943 Class Size: # of Donors: % of Participants: Total Gift: Dorothy G. Carman H. Russell Denegar Geraldine E. Howard Joseph F. Verrastro
8 3 38 $250
11 4 36 $850
1944 Class Size: # of Donors: % of Participants: Mary M. Andrews
4 1 25
1946 Class Size: # of Donors: % of Participants: Jean B. Chambers
9 1 1
1947 Class Size: # of Donors % of Participants: Total Gift: Mary S. Nellis Howard J. Slater Regina G. Snyder Frank J. Sweeney 1948 Class Size: # of Donors: % of Participants: Total Gift: Myron J. Bach Thomas C. Hanley Irmgard S. Kaiser Arthur J. McCann Mary E. Murphy Howard Schwartz 1949 Class Size: # of Donors: % of Participants: Total Gift: G. Robert Carney
17 4 24 $1,575
21 6 29 $435
42 10 24 $1,000
Thomas J. Connolly Arthur F. Dooley Betty B. Frink Marie R. Hare Arthur G. Margolis Edmond A. Robert John H. Schell John F. Sherman Norton W. Taylor 1950 Class Size: # of Donors: % of Participants: Total Gift: Leslie B. Coons Frederick S. Haggerty Eleanor Van Buren Messia Robert A. Messia Richard Miller Elizabeth V. Sheldon Stanley R. Stankes
50 7 14 $775
1951 Class Size: 62 # of Donors: 21 % of Participants: 34 Total Gift: $2,055 Patricia B. Carney Richard A. Eddy Leonard Every William B. Fizette Harold Jaffee Angelo A. Mercurio Melvin Mones Andrew E. Nielsen Anne K. Pierson Herbert V. Savage Harold W. Seitz Donald A. Sherman Eugene D. Sherman William L. Shumway David Silverhart Linford A. & Nancy W. Snyder Jr. Philip Teicher Robert W. Thorpe Donald D. Weinstein Walter H. Williams 1952 Class Size: # of Donors: % of Participants: Total Gift: Anonymous Edward A. Belemjian Donald H. Butlien Walter Cherniak Esten Coan David R. Corina Richard L. Culver Rinaldo V. DeNuzzo John D. Forman James Francese Jr. L. Jane Klippel Lester E. Maxik Joseph G. Mount William A. Petersen Frederick G. Pickles Richard G. Robison + Daniel Rubinson Robert C. Schmitt Jerome B. Shapiro Laura G. Tepper Robert H. Van Vlack Elwin E. VanValkenburg Thomas A. Wardwell Robert West
60 24 40 $14,015
ACPPresRepFINAL
4/4/08
1954 Class Size: # of Donors: % of Participants: Total Gift: Scott W. Brown James DeSorbo Francis J. DiLascia + George M. Ehrmann Lorraine P. Godson James E. Harrington Herbert D. Heitmuller Robert O. Hitchcock Melvyn M. Kost Marilyn A. Mc Carthy John J. Rivolta Jr. Walter F. Shangraw Jr. Alan P. Tubbs William R. Warner Eleanor S. Williams Edward W. Wind 1955 Class Size: # of Donors: % of Participants: Total Gift: Marilyn D. Browne Edward L. Burns June F. Cherniak Samuel A. Coppola Miriam L. Hogle Harold Kessler Salvatore J. Lanzafame William J. Lincourt William J. Mahanna Bruce D. Martin Melvyn Masters John D. Murphy George W. Rohde 1956 Class Size: # of Donors: % of Participants: Total Gift: Pat Faragon Thomas F. Flynn Jr. William Gonz Elizabeth J. Hamilton Murray P. Hyatt Paul A. Lanciault Edward A. Lenz Andrew R. Perkins Sr. Vincent F. Polvino James R. Spillan
54 11 20 $12,090
54 13 24 $4,545
44 13 30 $950
50 10 20 $1,125
Page 49
1957 Class Size: 57 # of Donors: 28 % of Participants: 49 Total Gift: $17,443 Anthony Albano Nick G. Anagnost P. Edgar Badgley Charles J. Bernas Jack E. Boylan Thomas E. Byrnes Kathleen M. Chapman Carol A. Ciufo J. Gordon Dailey + John L. Finnegan Angelo M. Friello Marilyn S. Green Gary D. Hall Jeanette S. Lamb + Barbara L. LaPorta Arthur J. Macarios Francis X. Magee Robert F. McGaugh + Frank E. Moreno Elsie W. Mulrooney Henry A. Palmer Ann M. Parillo Frank J. Piccirillo William J. Reilly Frederick G. Siegenthaler William R. Steed Lois Wind Wayne F. Woodcock 1958 Class Size: # of Donors: % of Participants: Total Gift: Anonymous Richard K. Barber G. Wesley Barnard James E. Bollinger + Elliot Cohen Ralph N. Comanzo Selig D. Corman Warren E. Doetsch Louis P. Fortin Melvin S. Friedland + Rocco F. Giruzzi Jr. Frank A. Hempstead John F. McCarthy Stephen I. Michaelson Robert S. Pomerantz Bertram A. Rapowitz Jack M. Rosenberg Robert W. Rozek Donald Seifert Dexter B. Spaulding Frank A. Viviani Mark L. Williams
67 24 36 $160,745
1959 Class Size: 63 # of Donors: 22 % of Participants: 35 Total Gift: $7,578 William B. Amsden Walter E. Byrne August J. Dobish Edward A. Fausel Warren D. Ficke William J. Finn Herbert T. Goggins Sr. Donald F. Hall David A. Hanson Lester R. Kleinman Arthur & Jeannie Kramer Allen J. Lieberoff Ralph T. Mancini
1960 Class Size: # of Donors: % of Participants: Total Gift: James H. Beatson Anthony Chiffy Sr. Claire D. Childs William J. Dwyer Rocco Femia Sr. Richard P. Fernandez Cynthia S. Gabriels Santo A. Garro Edgar L. Jorolemon Walter D. Kinnin Bertram L. Kohn Mary Lou Mancini Richard A. Marra Bernard Nowitz Carol R. Powell Ira H. Rheingold Carl E. Rosenfeld Robert M. Stote 1961 Class Size: # of Donors: % of Participants: Total Gift: Dorita G. Aboufadel Richard D. Baylis John A. Bottiroli Phyllis Cristo Pomeroy Celia F. Epstein Marilyn C. Fortin Roy F. Hammecker Eugene A. Hoh A. Joseph Kallfelz Susan N. Layne Ronald C. Menard Harry P. Norman Dennis R. O’Grady Richard A. Rubin Robert M. Santimaw Thomas A. Somlo David B. Van Etten F. Hamilton White III Barry F. Wishengrad Edward J. Wortley 1962 Class Size: # of Donors: % of Participants: Total Gift: Brian W. Bartle Baird C. Couch Dorothy M. Fausel Harry M. Fertik Floyd Firman Jr. Jon J. Gallagher Vincent M. Grimaldi Sr. Walter G. Hagues Elaine G. Henry Frank C. LaPuma Linda J. Lovejoy Edward P. Molloy Joan E. Murray James W. Nowicki Arthur A. Ramsey Elinor W. Smith
P 49
Robert H. Solomon David E. Talarico Thomas M. Techman Robert M. Toomajian Ronald L. Wilcox
Robert W. Miller Raymond J. Mooney Joseph P. Morris Katherine F. Petrone Joseph G. Rampe Janis E. Scott Edward J. Trnka John M. Walts
60 18 30 $4,200
73 20 27 $2,810
74 21 28 $7,360
1963 Class Size: # of Donors: % of Participants: Total Gift: Richard K. Aikens Elizabeth L. Austin Francis A. Carbone William A. Cetnar Richard H. Daffner + Gale L. Gridley Zachary I. Hanan + Diane G. Lubertine Francis E. O’Hearn P. Ronald Pollack Howard Rubinger Sandra R. Sansone John J. Sheeley Jr. Jay A. Sherline Karen A. Wortley Paul S. Zimmons 1964 Class Size: # of Donors: % of Participants: Total Gift: Lawrence J. Casey Jr. Janice M. Morrison Sheila Winnowski Mary Yates
88 17 19 $6,559
17 4 24 $450
1965 Class Size: 86 # of Donors: 19 % of Participants: 22 Total Gift: $5,045 Ronald A. Amedio Nicholas S. Bonarrigo Robert H. Brakemeier Nicholas & Nancy Chervinsky Timothy C. Colyer Robert D. Conklin Albert L. DiDonna Thomas S. Drahushuk Robert S. Edson David D. Edwards Thomas P. Gillette Stephen T. Godlewski Allan L. Haines Richard S. Heise Sandra F. Lory Mary E. O’Hanlon Georgiana S. Sichuk Richard E. Sobiski Ronald Winchell 1966 Class Size: # of Donors: % of Participants: Total Gift: Lee A. Anderson James P. Byrnes Mary L. Carney James E. Chaffee Gary R. Coloton Paul F. Consroe Susan D. Dahm John N. Erb Frank C. Flannery John C. & Jane C. Henty David S. Jackson Vicki S. Kelsey
71 25 35 $5,503
Albany College of Pharmacy PRESIDENT’S REPORT 2007
1953 Class Size: # of Donors: % of Participants: Total Gift: Alfred J. Collins Jr. + Albert A. Curri Joseph A. Fiscella Sr. Gilbert Fudin John J. Kwasnowski Virginia M. McBride Jack A. Monakey Eugene R. Ponessa Francis M. Steed Lewis W. Sturgess Robert E. Thiess
3:59 PM
ACPPresRepFINAL
4/4/08
3:59 PM
James J. Kitts Richard R. Little Jacqueline P. Merrick Philip R. Palumbo William T. & Kathleen M. Quackenbush III Thomas M. Sands William L. & Alice M. Sliter Robert A. Sofia Fred M. Thomas 1967 Class Size: # of Donors: % of Participants: Total Gift: Maria O. Bachynsky Frank C. Berning David R. Brooks Alan J. Carpenter Donald R. Charles Jr. Diane F. DeGroff William Delahant Jo-Adele C. Dumper Robert R. Henion III Richard L. Johnson Edward J. Mc Nulty David F. O’Connell Jeannette M. Rogowski Neil T. Schram Edgar V. Stevens 1968 Class Size: # of Donors: % of Participants: Total Gift: Steven L. Blakeslee David C. Brands Richard F. Cimildoro Anne Marie Crumb Geraldine A. DeGrazio Susann L. Dugo James J. Finn Jane W. Fox Suzanne J. Gaetano Raymond T. Giblin Lewis B. Helfstein John M. Ostrander Ronald S. Sahr William E. Sheeley Terrence T. Towers Suzette P. Usher A. John Wylie 1969 Class Size: # of Donors: % of Participants: Total Gift: Stuart A. Berney Alan Blum Albert G. Chmura Richard A. Cognetti Philip W. Cornell Lynne K. Cote George H. Crittenden David M. Goodrich Gene S. Gray Laurence S. Herman Patricia A. Howlett Sylvia M. Kaminsky David S. Knightes Rose E. Lang Lawrence E. Lenihan* John J. Longacker Barbara J. Olchek David M. Pelton Wallace B. Pickworth Robert A. Schaefer
79 15 19 $4,485
89 17 19 $3,635
88 24 27 $6,600
Page 50
Robert G. Single John V. Tagliaferri Doris R. Voigt 1970 Class Size: 77 # of Donors: 23 % of Participants: 30 Total Gift: $9,010 Harvey M. Arbit Ann Marie Z. Bowman Larry M. Burling Frank Capristo Jr. Ted Cohen Norma Jean W. Coloton John R. Cote Robert J. Craner William G. Davis Linda L. Drew John C. Huebeler John Edward Kirker John P. LeGrand Wayne A. Mabb Roxie J. Miles Stephen B. Morgan Philip P. Moyer Joseph S. Rebisz Edward J. Ryan Maryann M. Sheeley Richard W. Skeels John D. & Maria T. Wakefield 1971 Class Size: 78 # of Donors: 21 % of Participants: 27 Total Gift: $5,005 Jon P. Bushnell Angelo P. DelZotto William J. Furman Gregory P. George Benjamin P. Graham Bernard W. Graham David P. Hores Patrick E. Howlett Gary P. Johnson Paul F. & Ellen D. Koehler Stephen A. Koerts Kenneth R. LePage Paul M. Matala David W. McEntarfer John F. Mitchell Lawrence H. Mokhiber Thomas H. Neely Shery W. Richardson Larry E. Small Thomas B. Snow 1972 Class Size: 81 # of Donors: 27 % of Participants: 33 Total Gift: $4,915 Judith M. Beaulac John M. & Sheila B. Briglin Joseph R. Burgess Barbara H. George Mary Ann D. Godlewski Rose Maria S. Godlewski Doreen Z. Graham Theodore J. & Kathleen M. Hahn R. Gary Hollenbeck Michael B. Julius Michael B. Levine Robert J. Locke David J. Minarski Arthur W. Muldoon Robert A. O’Connor Patricia A. Pafundi Cynthia F. Phillips
Frank M. Piacente Gregg W. Richmond Ann V. Sawyer James H. Serour Charles A. Sharkey Sarah L. Shultz Carol G. Trautmann Leo A. Wisniewski 1973 Class Size: 72 # of Donors: 16 % of Participants: 22 Total Gift: $3,190 Alan F. Beck Ann Marie Conti-Kelly Greco Michael C. Federici Vincent A. & Kathleen M. Galletta James P. Hranek Paula H. Huebeler Marcia M. Locke Michael W. McEntarfer David J. Muller Andrew F. Nelsen Karl F. Popp Linda J. Ronk Gary M. Sanges Timothy D. Suenram Kurt E. Trautmann 1974 Class Size: 86 # of Donors: 28 % of Participants: 33 Total Gift: $8,817 Kandyce J. Daley + C. John Dean Kenneth P. Drabik Eileen L. Faist Richard C. Finkle Jeffrey P. Firlik Louis J. Fratto Jr. Wayne F. Geiser Frank L. & Marylee F. Grosso Joseph P. Guarino Peter W. Henry Wladmyr B. Jurkiw David M. + & Susan M. Kile Frederick J. Macri Henry C. Miller & Nancy Phillips David M. Murray Michael J. & Ann M. Osborne Vincent A. Pigula David A. Reagan Shirley C. Stolarski Jacqueline R. Thomas David E. Urban Richard J. Zalewski Jeffrey M. Zurek 1975 Class Size: 107 # of Donors: 23 % of Participants: 22 Total Gift: $3,335 Michael E. Belemjian Steven H. Berkowitz Daniel P. Christensen Glynis P. Clark Kim M. & Rose Mary C. Demers Phillip C. Fifield Ethel D. Frost Lawrence R. Goodspeed Marie L. Greener David A. Grella Owen W. Halloran Olesia Hollenbeck James E. & Lorraine F. Kewley Sharon A. Leary Timothy L. Magila
Jane M. O’Neill Mary Beth Poland Dominick J. Porco Thomas E. Roberts Diane B. Sacco Russell A. Yandon 1976 Class Size: 103 # of Donors: 24 % of Participants: 23 Total Gift: $2,875 Catherine M. Boudreau Michael J. Canale David C. & Maura B. Clark Robert F. Clark Joseph A. Colangelo Joanne Criscione McTague David J. Dalton Thomas Fiore Donald A. Fortier William Galarneau Christine T. Haack Rick N. Hogle Everett M. & Sally A. Hunt David A. Keyser Eric T. Klippel David J. Krazinski James E. Monahan Sara F. Nelsen Nancy S. Newkirk Marilynn O’Dell David M. Oles John T. Ward 1977 Class Size: 111 # of Donors: 23 % of Participants: 21 Total Gift: $2,771 Daniel M. Astry Fred E. & Marylourdes T. Brundige Edward E. Cretaro Erik A. Debruin David P. Demagistris Marlene G. Dickson James Farrell Shirley J. Fourman Deborah A. Grimes Lyle B. Hall Robert A. Hamilton Scott W. & Joan Hayes Paul G. Litynski Debra S. Masel Deirdre K. McEntarfer Michele Pallotta Therese I. Poirier Ingeborg S. Porco Linda E. Rosenthal Kathleen A. Toucher Donna W. Warren 1978 Class Size: # of Donors: % of Participants: Total Gift: Nancy L. Adlhock Maryjane Aiello Darrell S. Barber Jeffrey L. Bookhout David B. Castle Michael E. Collins Mark E. Connelly Michael J. Dillon Angela C. Dominelli William M. Fiero John P. Fratto Deborah B. Komoroski Jill R. Lang
114 25 22 $3,136
ACPPresRepFINAL
4/4/08
3:59 PM
William F. Shangraw Mitchell W. Wilbert Korey H. Willard Cynthia M. Wyman
1979 Class Size: 126 # of Donors: 36 % of Participants: 29 Total Gift: $5,205 Deborah R. Bauman Michael J. Bertoni James W. Bevilacqua Anne R. Blanchard Brian M. Carroll Stephen C. Corson Joyce M. D’Imperio Burton F. Deis Anthony N. Donatelli Wendy A. Dulin Rita A. Fahr Gregory A. Fuller James T. Gratch Terri R. Hanrahan Bruce D. Hatch Flory G. Herman Mark L. Hylwa David A. Kvancz Lea A. Lilie Mary Jo List Kathleen A. McCasland Earl W. Pease Mark J. Quackenbush Brian J. Richardson Mark A. Riegelhaupt James J. Roome Jr. Vincent L. & Melody W. Scavo Dale E. Smith Maria C. Steinbach Robert S. Sullivan Jr. Colleen D. Tebbe Patricia C. Wason Patricia D. White Rolf & Beverly Zakariassen
114 26 23 $4,145
1981 Class Size: 122 # of Donors: 33 % of Participants: 27 Total Gift: $5,710 Jolene R. Bates Raymond A. Bleser Cheryl A. Burtch Jane P. Butler David J. Carpenter Walter Czajka Barbara A. Duesler James W. Duffy Jill W. Edd Jeffrey Fudin Peter S. Gage John R. George Mark Gersten Kathleen M. Hayes Lorraine G. Herkenham Leigh A. Hill Alesa M. Hughto William C. Irwin Leon N. Kentner Janet S. Korwan Stephen C. Krom Frederick G. Miller Colleen H. O’Malley Linda B. Rosen Kathy A. Smith Nancy Ann M. Stellato Garen Szablewski Edward L. Toomajian David E. VanValkenburg John F. & Michele S. Walker Michael & Kimberly M. Zebrowski 1982 Class Size: 118 # of Donors: 30 % of Participants: 25 Total Gift: $2,510 Holly M. Bonsignore Jane K. Boyd Roseanne T. Burke Julie K. Burns Fred A. Carroll III Diane L. Chmel Joseph M. De Vito Marie Dropkin Joseph Fiscella Jr. Janet M. Johnson Peter M. Lamanna Theologos Malahias James & Marian E. McLaughlin Mark S. Palmer Laureen A. Parese Christine R. Petit Mark E. Pochal John S. Podesta Keith W. & Stephanie D. Preston Terrence K. Reid Kellie A. Sanzone Stephen R. Shearer James V. Skelly Karen A. Snyder Gale E. Soltys John P. & Evelyn M. Vavra Richard J. Zeppieri
1983 Class Size: 107 # of Donors: 24 % of Participants: 22 Total Gift: $8,280 David J. Bendyk Robert A. & Bonnie B. Blum J. Mark Bover Laurie M. Cronin Susan L. Cuculich Christopher J. DiLascia Thomas P. & Teresa Garcia Geno J. Germano Jr. Dorothea A. Griffiths Mary E. Haggard Sema E. Hart Bruce L. Hotchkiss Philip M. Hritcko Lisa Ann Mason Sean F. McCarthy Julius A. Pasquariello Andrew M. Polak John R. Ripley Sandra J. Shuhart David M. Tenero Michael D. Willson Patricia S. Wilson 1984 Class Size: 109 # of Donors: 26 % of Participants: 24 Total Gift: $5,007 Robin J. Alteri Cynthia L. Brown Suzanne E. Caravella Joanne M. Daprano Steven Fiero Anthony J. Graziano Edwin P. Greenman Jr. Debora House Paul E. Johnson Michael P. & Teresa H. Kane Roland J. Lyndaker Lawrence J. Mango Renata A. McKenzie Glenn A. Meyer Donald Morse Marion T. Morton Jeffery W. Opal Matthew F. Pearsall Douglas F. Perryman Bonnie T. Peters James H. Purcell Cynthia M. Rella Harris Richard D. Robertello Suzanne S. Trombley Daria F. Yuschak 1985 Class Size: # of Donors: % of Participants: Total Gift: Jacqueline A. Aldershoff Anne E. Astemborski Anne T. Carlisto Tracey A. Denardo Carla A. Desrosiers Arthur L. Forman William O. Griffiths Wendy M. Gwozdz Steven B. Hansel Christopher J. Klein Maya Kurtz Teresa J. Lubowski Michael L. Maggy John T. McDonald III Cathy M. Osborne Lisa A. Palmer
121 24 20 $6,710
Carolyn A. Peebles Samuel T. & Naomi M. Piraino Gary H. Seaward Troy D. Spaulding Mary Kelly Sutphen Scott Terrillion Cathy A. Tillman 1986 Class Size: 129 # of Donors: 33 % of Participants: 25 Total Gift: $7,825 Jennifer L. Battin Jennifer Caloia Christine V. Camille Mariangela K. Capozzi Michael J. Clarke Mark A. Desieno Paula M. DiLascia Wright Karen B. Fiero Theresa B. Germano Joyce Hansel Chris A. Haritos Diane C. House Amy C. Hutchison Matthew D. & Lynne K. Lee Rose Ann M. Manning Kenneth J. & Julie Chang Maxik Patrick McLaughlin Patricia A. McMahon Jana D. Mula Scott W. Murray Martha Naber Christopher G. Palmer John F. Peebles Robert C. & Becky B. Petronio Jr. John E. Romeo Gary J. Salamido Michael S. Sherwood Anne M. Sowinski Fred Valenti Mark Yerushalmi 1987 Class Size: 130 # of Donors: 28 % of Participants: 21 Total Gift: $5,488 Sidney C. Anderson Richard A. Billington Dominick A. Bizzarro Diana R. Boschi Leigh Briscoe-Dwyer Sandra M. Clarke Astrid L. Cook Everett D. Cronizer James F. Cross Christopher A. & Kathleen Fama Lori E. Farquhar Philip K. Favreau Jr. Suzanne A. Figary Andrew G. Flynn Gregory G. Guimond Anne Marie D. Hume Bernard G. Janeczko Barbara J. Joyce Frank H. & Susan M. Klippel Roger A. Lemke Jr. Janice T. Martino Sondra G. Powers Cynthia S. Sadauskas Kelly E. Toia Lori Weaver
P 51
Albany College of Pharmacy PRESIDENT’S REPORT 2007
Peter W. MacArthur Kathleen Morse Julie C. Pearson Roxanne H. Richardson Joseph P. Sanzone Kim L. Sprague Linda C. Staples Wayne F. Vallee Gretchen S. Welge John T. Westerman Jr. Karen S. Whitney Christine M. Wood
1980 Class Size: # of Donors: % of Participants: Total Gift: Sam F. Berardino III Kathleen Bibbo Lisa E. Bonner Michael P. Butler Elizabeth C. Frank Gary L. Grella Wayne W. Halayko Bridget-ann Hart + Michael S. Hayes Lisa M. Houk Lory L. Huller Christie H. Hylwa Mark P. Laurin Douglas R. Lindke Edward A. Loeber Joseph N. Marzo Constance S. Matthys Theodore L. Mitchell Jeffrey A. Newell Irene T. Przylucki Frank M. Riley William F. Schlomberg
Page 51
ACPPresRepFINAL
4/4/08
3:59 PM
1988 Class Size: 125 # of Donors: 18 % of Participants: 14 Total Gift: $5,970 Debra L. Barber Colleen A. Cross Christopher DelVecchio + Sean C. & Imelda N. Dobbins Barbara N. Favreau Jeffrey C. & Darlene E. Garbin Marcia A. Kall Mary K. Lettko Paul Mangione Jr. Lynn K. McKinnon Darren M. Pynn Barbara J. Rogler Larry G. Tabor Tamara H. Turner Kathleen M. Wyatt Cynthia L. Young 1989 Class Size: 148 # of Donors: 24 % of Participants: 16 Total Gift: $3,131 Pamela M. Bowers Colleen W. Breault Tammy Brown Jill M. Corbett Robert J. & Maryanne Davis Shanna A. Fitzpatrick Kelly L. Flynn Julie-Ann Fortran Lorie A. Giamartino Lori Hunt Nancy H. Huntington Mary Beth Juron David O. Lange Kimberly A. Leonard Becky L. McNulty Lori A. Mosher Jacquelyn A. Peters Mitchell Bridget O. Rowan Joseph F. & Elena M. Scrivo Michael J. & Stephanie A. Sessa Jr. 1990 Class Size: 112 # of Donors: 18 % of Participants: 16 Total Gift: $1,870 Ellen M. Aschbrenner Jeremiah S. Axtell Wendy H. Berger John A. Carriola Clayton D. Edwards Michele M. Fernandez James T. & Wendy W. Galgano Stephen J. Kwasnik Jean A. Lange Edward T. Lanoue Nicholas W. Lotano William E. Peck Michael J. Reff Brenda J. Rutherford Carlos N. & Sarah C. Velez Mary E. White 1991 Class Size: # of Donors: % of Participants: Total Gift: Mary E. Billington Kathleen E. Bonnier Donald T. Collea Joseph A. Comito Jaclyn K. Dacier
141 23 16 $7,600
Page 52
Sara L. DelVecchio Adam T. Drahushuk Tania M. Durante Mark T. Edgerly Michelle B. Edwards Michael R. Fernandez Ellen L. Kennett Jeffrey J. Kirkby Maureen A. Millen Katy-Erin Miller Mary Lou Notaro Karla M. Palmer Manuel Ramirez Nancy J. Randall Michelle B. Reff Richard A. Sadekoski Marc L. Watrous 1992 Class Size: 140 # of Donors: 26 % of Participants: 19 Total Gift: $2,300 Richard S. & Tracey L. Andrews Alan M. & Cory A. Bernstein Elke M. Blaetz Sharon G. Bridgeford Regina V. Dascher Robert P. Galer L. Thomas & Maureen Geiser Laurie A. Govel Sharon K. Harper John M. Kwasnik Paul G. & Mary Jo G. Lakomski Lisa R. LaLoggia Jacqueline A. Matikiewicz Sandra L. McLoud Kimberly C. Meyer Denise A. Nero Gregory Notaro Glen F. Palmer Scott C. Preische Frank M. Reff Kristin N. Renzi Keith E. Stanley Patricia A. Zagami 1993 Class Size: # of Donors: % of Participants: Total Gift: Thomas W. Algozzine Mary E. Coolidge Susan M. Couture Barbara A. Forster Julie M. Galer Judy J. Izard Chong Ki Kim Dale R. Lewis Tiffany I. Loder Robert Makofske Joseph D. Manley Michael A. Panasci Kim M. Reynolds Christine L. Robataille Diane G. Schroeder Gregory J. Sciarra Laura A. Stevens Carolyn M. Stock Brian J. Summa Kevin D. Valade Jon K. Vorreuter Jean M. Witkowski
120 21 18 $4,135
1994 Class Size: # of Donors: % of Participants: Total Gift: Lisa A. Baumander Joseph Chiffy Susan K. Conklin Bonny K. Decastro Victoria R. Dingman Kelly M. Doan Derek E. & Amy M. Fluty Margaret W. Karl Kristen M. Kim Philip K. LaFluer Jr. Cecile H. Lewis Maureen E. Mack Margaret E. Morris Krista M. Nelson Lori A. Panasci Matthew Scott Susan E. Smith Erin E. Southwick Susan L. Torpey Tina M. Valdeon Nicole M. Van Alstyne Ruth-Ellen Van Arnam Dina V. Vorreuter
136 24 17 $2,385
1995 Class Size: 126 # of Donors: 19 % of Participants: 15 Total Gift: $1,396 Annabelle S. Bink Maria D. Bruggemann Sanjay N. Gandhi Rebecca M. Hilborn Allison A. Hoff Jeremey J. & Christine M. Jorolemon Ellen J. Kenney Emerson S. Metzler Mark E. Morin Christine M. Mulhern Robert D. & Rosanna O’Brien Anna O’Neil Rachelle E. Perry Catherine A. Salvagni Tracey J. Toner Vincent J. Zammiello 1996 Class Size: 122 # of Donors: 18 % of Participants: 15 Total Gift: $2,161 Kevin A. Barnhart Bradd J. Beimford Brian A. & Stacy Bruyns John J. Faragon Ursula Gandhi Christopher T. Horning Kenneth A. Hoyt Nicole L. Jareo Thomas J. Natalie Melissa A. O’Hara Matthew M. Piskun Ronald V. & Brandi L. Romano Mary Kay Terrell Denise C. Thoma Margaret E. Turoski Jennifer Zammiello
1997 Class Size: 133 # of Donors: 21 % of Participants: 16 Total Gift: $2,830 Christie L. Andrews Alfred A. Austin Jr. Erin M. Buckley Peter T. & Melissa A. Burdash Christine M. Daniel Corey J. Duteau Mark W. Fagnan Robert J. Fountaine Laurel S. Graziano Kyoung-Sil Kang Jennifer R. Landaverde Theresa A. Lee Heather A. Manley Michael T. Miller Jennifer L. Munoz Brendan P. O’Hara Diane P. Scott Angela Wisniewski Mario M. Zeolla* 1998 Class Size: 146 # of Donors: 12 % of Participants: 1 Total Gift: $740 Amanda L. Allen Kelly L. Anderson Jennifer J. Cotton Denise L. Hornbeck Mark A. Hunter Christopher A. La Pierre Joanne M. Race Gary E. Sambrook Jr. Mark E. & Kristen M. Scanio Greg R. & Michelle M. Stanley 1999 Class Size: 130 # of Donors: 19 % of Participants: 15 Total Gift: $2,115 Joseph L. Breton Andrea M. Brooke James D. Cataldi Rebecca A. Conrad J. Michael Darbyshire Brian R. Dodge Michael S. Dufort Kevin J. Fessler Ivan S. Law Laura Le Lisa A. Lipp Amanda K. Nuzzo Krista A. Pahler Carl J. Possidente Richard A. & Tanya S. Sillato Jennifer Stone Susan E. Yerry Christine M. Zeolla 2000 Class Size: 109 # of Donors: 6 % of Participants: 1 Total Gift: $1,540 John C. Coultry Sean P. Greene Karen L. Smith Christopher A. Tomchik Michael G. & Trisha A. VanDerwerken
ACPPresRepFINAL
4/4/08
2002 Class Size: # of Donors: % of Participants: Total Gift: Judson Anderson Jason M. Blitz Nicole M. Janiszewski Jerrod C. Richards Leila M. Tibi Jason R. Warner 2003 Class Size: # of Donors: % of Participant Total Gift: Nicole N. Darbyshire Erin E. Dorval John M. Marraffa Jr. ^ Mary Beth Marten & Teryl A. Romeo ^
111 9 1 $875
138 7 1 $450
126 5 1 $1,800
2004 Class Size: # of Donors: % of Participants: Nicole A. Bulmer
130 1 1
2005 Class Size: # of Donors: % of Participants: Joshua J. Dorval
123 1 1
2006 Class Size: # of Donors: % of Participants: Total Gift: Kaitlin M. Cunningham Suzette A. Pablo ^ Timothy C. Randolph 2007 Class Size: # of Donors: % of Participants: Michael P. Daprano
148 3 1 $580
144 1 1
Page 53
Friends of Albany College of Pharmacy Trustees, Faculty, Staff, Administration, Parents and Friends Total Gift: $262,418 James L. Anderson Anonymous Patricia Baia Indra Balachandran Pradip & Sukla Barat # Nicholas Barbuto Jr. Allen Barnett Karen Barrows Donna Beebe Michael F. Bette + James E. Bollinger ’58 + Mehdi Boroujerdi Robert D. Boroujerdi David & Catherine Bousquet # Michael J. Buckley Robert A. & Mildred Burke # Norman & Shirley Burman # Robert S. Busch + Shelly A. Calabrese Lucille Cerro Gilbert Chorbajian Herbert G. + & Linda Chorbajian Daniel & Jeanne Ciampino # Alfred J. Collins Jr. ’53 + Carly Connors Kevin & Sally Cope # William M. Cronin Richard H. Daffner ’63 + J. Gordon Dailey ’57 + Kandyce J. Daley ’74 + Donald W. & Linda D. Davison # Thomas & Lynne DellaRocca Christopher ’88 + & Sara L. ’91 DelVecchio John J. Denio Rinaldo V. DeNuzzo ’52 Francis J. DiLascia ’54 + Vicki A. & Michael W. DiLorenzo Angela C. Dominelli ’78 Deanna Ennello-Butler Hua Fan Andrew G. ’87 & Kelly L. ’89 Flynn Louis ’58 & Marilyn ’61 Fortin Melvin S. Friedland ’58 + Jan Frodyma Bhupendra & Minaxi Gadani # Irwin C. Gerson Steve & Youngna Goh # Lewis Golub Howard & Jill Goodkin Gail Goodman Snitkoff James J. Gozzo Martin J. Green Anthony & Elizabeth Gugino # Robert A. Hamilton ’77 Zachary I. Hanan ’63 + Jacqueline Harris Bridget-ann Hart ’80 + James R. & Robyn D. Hatch # James J. & Gloria Hunter Susan L. Iwanowicz Hugh A. Johnson Jr. + Michael P. ’84 & Teresa H. ’84 Kane Gerald Katzman Sally Ann Kay Ellen L. Kennett ’91 William & Barbara Kewley # David M. ’74+ & Susan M. ’74 Kile Myron Kligerman
Mathew & Lissy Kochupurackal # Stephen & Elaine Kovary # Jeffrey H. & Lesia Kurtz # Jeanette S. Lamb ’57 + Heather Landry David Langley Joseph M. Lapetina + Josie Leighton Ralph & Donna Leonardi # Ronald E. Lesko Bertram Lieberman Leonard C. Lipkin Teresa J. Lubowski ’85 John A. & Mary B. Lyons # Thomas O. Maggs + Jacob & Mercy Malathu # Gerard & Madeline Marinaccio # Ronald W. Mason Robert F. McGaugh ’57 + Patrick S. McGraw Catherine Merriman Nicholas Mesiti Ronald & Nancy Michonski # Harry J. Mikhitarian ’54 Memorial Fund Kenneth W. Miller William R. Millington Fouad & Amal Morkos # Shaker A. Mousa Lee M. Nackman Robert E. L. Nesbitt John Nieckarz Adwoa Olufunlayo Nornoo Justin & Pamela Orlando # Patricia F. Osowick Ruth Peckham Victoria A. Peters John Son & Nancy Nga Pham # Richard & Lori Pratt # Henry K. & Janina Prusaczyk # Dominic & Tina Raco Gary & Doreen Randolph # William & Elaine Ray # Barry S. Reiss Deborah S. Reutter Armand Rivers Richard G. Robison ’52 + Scott F. Rogler Mary Anne Ross Carol Ju & David M. Rubin Walter & Geraldine Samselski # Bernard E. Schallehn Christine Shields Michael & Joan Sinai Reid H. Sperber Christina Spinelli Robert & Marian Tompkins # Terrence T. Towers ’68 Ryan P. Venter Frances Verderame Diane Vincent Leo & Julie Waseleski # Thomas D. Weaver Carolyn White Frank & Melanie Wojak # John Woychick David Zdunczyk Giuseppe & Maria Zeolla Mario M. ’97* & Christine M. Zeolla ’99
P 53
Albany College of Pharmacy PRESIDENT’S REPORT 2007
2001 Class Size # of Donors: % of Participants: Total Gift: Tracey L. Coultry Michael P. Flannery Thomas Grandville Srividya Kotapati Michael S. Leake Susan M. McAndrew John D. McGrath Clyde T. Stevens Michael J. Zeolla
3:59 PM
ACPPresRepFINAL
4/4/08
3:59 PM
Page 54
Corporations and Foundations Total Gift: $327,646
Abbott Laboratories Accent Commercial Furniture, Inc. Ace Pest Control Specialists, Inc. Action Window Cleaning Co., Inc. Albany Law School Albany River Rats/Albany Conquest Allen’s Upholstery and Carpet Cleaning American Chemical & Equipment Co. American Eagles G. B. C. Anonymous Audio Video Corporation Thomas Babcock Investment Advisers LLC Bank of America Benefit Resource, Inc. Bette & Cring, LLC Burkins & Foley Trucking and Storage, Inc. Jack Byrne Ford & Mercury Inc. Capital Area Pharmacists Society Century House Chubb Colonie Mechanical Contractors, Inc. ComDoc, Inc. W.L. Coughtry/Dataflow Curtis 1000 CVS DepeDene Resort The Desmond S.J. Dooling Building & Remodeling Envision Architects PC Envision Communications Consultants, LLC Excel Engineering, P.C. Excel Systems Inc. Flooring Environment, Inc. Follett Higher Education Group Gateway Companies Inc. Hannaford Supermarkets Heslin Rothenberg Farley & Mesiti P.C. Hession Electric, Inc. Higher Education Marketing Associates, Inc. Hiland Park Country Club Hiscock & Barclay, LLP Indian Ladder Farms, Inc. InterfaceFlor Commercial J C B Specialties, Inc.
J M T Brokerage, Inc. Johnson Illington Advisors, LLC King Venetian Blind & Drapery, Inc. Kinney Drugs Foundation, Inc. KONE, Inc. Krackeler Scientific, Inc. Londonderry Café Mabey’s Moving & Storage, Inc. Mahoney Notify-Plus Inc. Markel Insurance Company Merrill Lynch & Co., Inc. Metro Resources, LLC Milliman Consultants & Actuaries Moore Fire Extinguisher Company LLC National Association of Chain Drug Stores nfrastructure Normanside Country Club Northeastern Fine Jewelry The Otesaga Hotel Pepsi Pharmacist’s Letter Price Chopper QS / 1 Data Systems RBC Capital Markets RBM Guardian Fire Protection, Inc. Rite Aid Corporation Robinson Hall Architectural The Robison Family Foundation Rose and Kiernan, Inc. John Savoy and Son, Inc. Saxton Signcorp Sentron Associates, Inc. 677 Prime Sodexho Inc. & Affiliates Sonitrol of Albany Stants Combustion Assoc., Inc. Stulmaker, Kohn & Richardson TD Banknorth, N.A. Tech Valley Communications Technical Building Services Time Warner of Albany, N.Y. TurfLinks, Inc. Walgreens Wal*Mart Stores, Inc. WeatherGuard Roofing Co. WebMD Wegmans Food Markets, Inc. Westmere Beverage Center
Matching Companies Total Gift: $23,723
Amgen Foundation Bristol-Myers Squibb Company Brooks/Eckerd Pharmacy Cardinal Health Eli Lilly and Company Express Scripts/Value Rx GE Foundation GlaxoSmithKline, Inc. IBM Corporation Kinney Drugs Foundation, Inc. Lockheed Martin Merck Partnership for Giving Novartis U.S. Foundation P & G Fund Pfizer, Inc. Publix Super Markets Charities, Inc. Roche Sanofi-Synthelaboratories Pharmaceuticals, Inc. Vanguard Group Foundation Wyeth
In-Kind Gifts Albany River Rats/ Albany Conquest Benefit Resource, Inc. Jack Byrne Ford & Mercury Inc. Century House Curtis 1000 DepeDene Resort Follett Higher Education Group Hannaford Supermarkets Hiland Park Country Club Indian Ladder Farms, Inc. Kinney Drugs Foundation, Inc. Londonderry Café Myron Kligerman Metro Resources, LLC Normanside Country Club Northeastern Fine Jewelry The Otesaga Hotel Pepsi Price Chopper QS / 1 Data Systems Sanofi-Aventis 677 Prime Stewart’s Shops Walgreens Wegmans Food Markets, Inc. Westmere Beverage Center
ACPPresRepFINAL
4/4/08
3:59 PM
Page 55
P 55
Albany College of Pharmacy PRESIDENT’S REPORT 2007
In Memoriam In Memory of Armante J. Cerro Thomas Fiore ’76 Santo Anthony Garro ’60 In Memory of Professor John Flynn Theologos Malahias ’82 Terrence K. Reid ’82 Stephen R. Shearer ’82 In Memory of Charlotte I. Forman John D. Forman ’52 In Memory of Frank G. Giamartino ’76 William Galarneau ’76
In Memory of M. Eileen (Brennan) Pratt Richard & Lori Pratt # In Memory of Victor G. Ross ’73 Mary Anne Ross In Memory of Noah A. Sorensen ’97 Rinaldo V. ’52 & Lucy B. DeNuzzo In Memory of Donna Stickler Arthur G. Margolis ’49 In Memory of Rosemary S. Toomajian ’81 Edward L. Toomajian ’81
In Memory of Fred Isabella ’42 Janis L. Best ’42
In Memory of Matthew Verderame Rinaldo V. ’52 & Lucy B. DeNuzzo
In Memory of Bruce G. Kay ’66 Philip R. Palumbo ’66
In Memory of Albert D. Warner William R. Warner ’54
In Memory of Rita E. Leighton ’86 Steven ’84 & Karen ’86 Fiero Patricia A. McMahon ’86
In Memory of Dean Albert M. White Pat Faragon ’56 Sharon K. Harper ’92 William J. Lincourt ’55 Frederick G. Siegenthaler ’57 William R. ’57 & Margaret Steed
In Memory of Donald A. McAndrew ’62 John J. Sheeley Jr. ’63 In Memory of Dr. Larry McDonald John ’82 & Evelyn ’82 Vavra In Memory of James L. McGuiness ’71 Kenneth R. LePage ’71 In Memory of Thomas F. & Lina Meaney Ellen M. Aschbrenner ’90 In Memory of Colleen (Coogan) Monje ’72 Judith M. Beaulac ’72 In Memory of Varant H. Najarian William R. ’57 & Margaret Steed Mitchell W. Wilbert ’80 In Memory of Dean Francis J. O’Brien Edward J. Mc Nulty ’67 In Memory of Julius J. Osowick ’55 Patricia Osowick In Memory of Robert Powell Carol R. Powell ’60
In Memory of Mario M. Zeolla ’97 John C. Coultry ’00 William M. Cronin Christine M. Daniel ’97 Rinaldo V. ’52 & Lucy B. DeNuzzo John J. Faragon ’96 Michael P. Flannery ’01 Andrew G. ’87 & Kelly ’89 Flynn Sanjay N. Gandhi ’95 Howard R. & Jill Goodkin Gail Goodman Snitkoff Laurel S. Graziano ’97 Alesa R. Hughto ’81 Michael P. ’84 & Teresa ’84 Kane David A. Kvancz ’79 Julius A. Pasquariello ’83 Pharmacist’s Letter Brian J. Richardson ’79 Barbara J. Rogler ’88 Michael & Joan Sinai Denise C. Thoma ’96 WebMD Edward J. Wortley ’61 David Zdunczyk Christine M. Zeolla ’99 Giuseppe & Maria Zeolla
In Honor of In Honor of Professor Joseph Lapetina Stephen I. Michaelson ’58 In Honor of Maria Tam T. Pham John Son & Nancy Nga Pham #
* # ^ +
Deceased Parent of current student Young Alumni Society Trustee
ACPPresRepFINAL
4/4/08
3:59 PM
Page 56
It’s Elementary...
T H E F U T U R E O F A C P I S I N YO U R H A N D S . Make a gift that makes a difference > A bequest > Life insurance > Real estate > A gift from which you receive income, such as a Charitable Remainder Trust, Pooled Income Fund or Annuity > A Charitable Lead Trust
To learn more about the Francis J. O’Brien Society contact: Donna Beebe Director of Major Gifts (518) 694-7125 beebed@acp.edu
•CoverFINAL
4/4/08
3:54 PM
Page 2
Albany College of Pharmacy James J. Gozzo, Ph.D.
Mehdi Boroujerdi, Ph.D., Pharm.D.
PRESIDENT
DEAN
Board of Trustees OFFICERS
TERM TRUSTEES
CHAIRMAN EMERITUS
Kandyce J. Daley ’74
Stephen C. Ainlay James E. Bollinger ’58 Robert S. Busch Herbert Chorbajian J. Gordon Dailey ’57 Richard H. Daffner ’63 Francis J. DiLascia ’54 Melvin Friedland ’58 Bridget-ann Hart ’80 Hugh A. Johnson David M. Kile ’74 Jeannette S. Lamb ’57 Joseph Lapetina Thomas O. Maggs Richard G. Robison ’52
Alfred J. Collins Jr. ’53
CHAIR
Zachary I. Hanan ’63 VICE CHAIR
Christopher Del Vecchio ’88 TREASURER
Robert F. McGaugh ’57 SECRETARY
TRUSTEE EMERITUS Kenneth M. Nirenberg
Research Contact Information OFFICE OF GRANTS ADMINISTRATION
PHARMACEUTICAL RESEARCH INSTITUTE
George Bailie, Pharm.D., Ph.D.
Shaker A. Mousa, Ph.D.
ASSOCIATE DEAN OF RESEARCH AND GRADUATE EDUCATION 518.694.7235 bailieg@acp.edu
EXECUTIVE VICE PRESIDENT AND CHAIRMAN 518.694.7397 mousas@acp.edu
Sunita Chowfin GRANTS ADMINISTRATOR 518.694.7144 chowfins@acp.edu
Diane Vincent GRANTS ACCOUNTING MANAGER 518.694.7313 vincentd@acp.edu
Office of Institutional Advancement Donna Beebe
Vicki A. DiLorenzo
Deborah S. Reutter
DIRECTOR OF MAJOR GIFTS 518.694.7125 beebed@acp.edu
VICE PRESIDENT OF INSTITUTIONAL ADVANCEMENT 518.694.7331 dilorenv@acp.edu
COORDINATOR OF INSTITUTIONAL ADVANCEMENT 518.694.7220 reutterd@acp.edu
Deanna Ennello-Butler
Christine A. Shields
DIRECTOR OF ADVANCEMENT RESEARCH 518.694.7305 ennellod@acp.edu
DIRECTOR OF COLLEGE PUBLICATIONS 518.694.7389 shieldsc@acp.edu
Patrick Rathbun
Christina Spinelli
ASSISTANT DIRECTOR OF MARKETING AND COMMUNICATIONS 518.694.7131 rathbunp@acp.edu
COORDINATOR OF DONOR RELATIONS AND STEWARDSHIP 518.694.7193 spinellc@acp.edu
Michael Buckley MAJOR GIFTS OFFICER 518.694.7126 buckleym@acp.edu
Gil Chorbajian EXECUTIVE DIRECTOR OF MARKETING AND COMMUNICATIONS 518.694.7394 chorbajg@acp.edu
Lynne M. DellaRocca SYSTEMS ADMINISTRATOR 518.694.7253 dellarol@acp.edu
David Zdunczyk ASSISTANT VICE PRESIDENT OF INSTITUTIONAL ADVANCEMENT 518.694.7251 davidz@acp.edu
The 2007 Report of Gifts includes donations of $100 and up received from January 1, 2007, to December 31, 2007. Gifts received after December 31, 2007, will be included in the 2008 Report of Gifts. The accuracy of this report is important to us. Please contact the Office of Institutional Advancement at (518) 694-7253 to report any inaccuracies or omissions so that our records can be corrected.
•CoverFINAL
4/4/08
3:54 PM
Page 3
ALBANY COLLEGE OF PHARMACY 106 New Scotland Avenue Albany, New York 12208
NON-PROFIT ORGANIZATION U.S. POSTAGE
PAID ALBANY, NY PERMIT NO. 349